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Abstract
Around one in five pregnancies end in spontaneous abortion. There are many causes for 
spontaneous abortion and these are discussed in this thesis. The body o f a pregnant women 
has to tolerate a foetus which receives its genetic material from both parents, and as such is 
essentially an allograft. Normal pregnancy is therefor a complex challenge to the immune 
system. The cause o f some abortions is unclear and it has been suggested that some 
abortions may be due to immunological factors.
For this study blood samples from normal non pregnant women, normal pregnant women 
and women undergoing a spontaneous abortion were collected. Isolated peripheral blood 
lymphocyte cells from the various patient groups were set up in tissue culture. The cells 
were then stimulated with mitogens and the turn-over o f cells and production of 
immunoglobulins was assessed.
Measurement o f some cytokine and thyroid antibody levels in the peripheral blood was 
carried out using enzyme linked immunoabsorbant assays (ELISA).
Damage caused by the formation o f reactive oxygen species, or free radicals, has been 
implicated in a number of pathologic conditions. In this study samples from the above 
groups were assayed for free radical scavenger levels.
Compared to normal non-pregnant women, pregnant women were found to have lower 
IgG levels and raised free radical scavenger levels. Spontaneous aborters also had raised free 
radical scavenger levels, but no significant difference in IgG levels was detected.
Cytokine levels were significantly different in non-pregnant or pregnant women compared 
to spontaneous aborters.
Thyroid antibodies were not detected in the serum of either non pregnant or pregnant 
women. However, 4 out o f 11 recurrent aborters (ie women who had suffered more than 
three spontaneous abortions) were found to be positive for thyroid antibodies.
The significance o f these findings is discussed.
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Chapter One
General Introduction
1.1 Incidence of spontaneous abortion
Spontaneous abortion, or the spontaneous loss o f a pregnancy, is 
emotionally traumatic for the patient and her family and a vexing problem for 
the physician, especially where the condition recurs. The word abortion comes 
from the Latin aboriri- to go away, to perish.
Reports in the literature o f the percentage o f pregnancies that end in 
spontaneous abortion vary to a large degree. This is partly due to study design. 
Where pregnancy testing is carried out on a daily basis, from ovulation onwards, 
more positive results will occur than where testing is carried out after missed 
menses. A number o f these "early positives" will abort before pregnancy is 
clinically diagnosed or by the time o f maternal awareness o f pregnancy (usually 
after a missed period). Some studies consider only pregnancies detected at time 
o f maternal awareness. Writing an hypothesis in the Lancet, Roberts and Lowe 
(1975) suggested "that in England and Wales married women aged between 20- 
29 may on a conservative estimate abort 78% o f their conceptions." They wrote 
o f "Nature resorting to abortion to maintain genetic stability."
Unsuspected pregnancy loss occurs where there is only biochemical proof of 
pregnancy, and this has led to researchers doubting the validity of other workers 
research. Whittaker et al (1983) found a spontaneous abortion rate o f 12% for 
clinically obvious abortion and a further 8% of abortions based on circulating 
levels o f human chorionic gonadotropin (HCG).
Figures o f between 15 and 20% are usually given in the literature for the rate o f 
spontaneous abortion in clinically recognised pregnancy. If miscarriage always
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recurred randomly and we take the figure o f 15% of all pregnancies that end in 
miscarriage, we would expect 0.4% o f women to miscarry three consecutive 
pregnancies. The observed frequency however is about 0.8-1.0% (Regan, 1991), 
indicating that recurrent miscarriage occurs much more often than would be 
predicted by chance. Regan says that even after three consecutive miscarriages 
the chance o f a successful pregnancy is as high as 60%, a fact that can confuse 
statistics, as each success after treatment is more likely to have been due to 
spontaneous recovery than to the treatment given.
1.2 Classification of abortion (from de Gruyter 1988)
Induced abortion is the deliberate termination o f pregnancy. 
Spontaneous abortion is the expulsion o f a foetus from the womb before 24 
weeks o f pregnancy. This can be complete, where all the products o f conception 
(foetus, amniotic sac and placenta) have come away, or incomplete, where some 
products o f conception remain in the uterus, the patient presenting with 
bleeding that continues and symptoms o f miscarriage that do not gp away.
After 24 weeks the spontaneous ending o f pregnancy is termed a still birth if the 
baby is bom dead or premature delivery if  the baby is alive.
Primary aborters are women who have never had a successful pregnancy, while 
women who abort and have had a previous live birth are termed secondary 
aborters.
A missed abortion occurs where the foetus has failed to develop or has died but 
is not immediately expelled.
3
Recurrent abortion is the term used where three or more spontaneous abortions 
have occurred.
1.3 C auses of spontaneous abortion
The cause o f spontaneous abortion may be explained in about half o f  all 
cases, the causal factors being;
1.3.1 The foetus
Chromosomal/  non-chromosomal abnormalities. H alf o f all abortuses o f eight to fifteen 
weeks gestation are found to be chromosomally abnormal (Simpson 1980) The 
number o f spontaneously aborted foetuses with structural (non-chromosomal) 
abnormalities is extremely difficult to define. Tissue degeneration due to 
maceration hinders detection o f such abnormalities. Neural tube defects were 
found at a rate o f 36 per 1000 spontaneous abortions in one study (MacHenry
1979). The incidence o f this defect among spontaneously aborted foetuses is 
many times greater than is found at birth.
1.3.2 The mother
Fibroids, (benign tumours in the uterus),
Anatomical abnormalities, i.e. malformed uterus, incompetent cervix. One study 
(Ayers et al 1982) o f 66 patients with recurrent abortion found that 42 had a 
widened uterine isthmus as their only abnormality. First trimester cervical 
effacement occurred in 90% of these patients. Using a combination of 
progesterone administration and surgical intervention (McDonald cerclage),
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begun in early pregnancy, successful term pregnancies were achieved for 97% of 
those patients treated. The Medical Research Council and Royal College o f 
Obstetricians and Gynaecologists published results o f a multicentre randomised 
trial o f cervical cerclage (McNaughton et al 1993). This study concluded that 
cervical cerclage should be offered to ‘high risk’ women i.e. those with a history 
o f three or more pregnancies ending before 37 weeks gestation.
Systemic Disease/Endocrine problems, e.g. kidney disease, hypertension, thyroid 
disorder, diabetes (Ritchie 1995).
Age. Women over 35 years o f age run a higher risk of foetal death than younger 
women (Fretts 1995). A possible explanation for this is the failure o f the uterine 
vasculature, in older women, to adapt to the haemodynamic demands of 
pregnancy (Naeyel983).
1.3.3 Both or other
Time of fertilisation. The risk o f spontaneous abortion increases with post 
ovulatory ageing o f the ova and also with the age o f sperm (Guerrero V, 1975).
Semen abnormalities, especially severe oligospermia (low sperm count) (Daya 
1994).
Contraception. Unplanned pregnancies which occur where the mother has an 
inter-uterine contraceptive device (coil) fitted are at increased risk of 
spontaneous abortion. I l l  out o f 177 such pregnancies (62%) spontaneously 
aborted in one study (Vessey 1979). Spermicidal creams slightly increase the risk 
of spontaneous abortion.
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Diet. Dietary deprivation is known to induce foetal loss in rabbits (Matsuzawa 
1981). Diets deficient o f certain elements are also known to cause abortion. Poor 
vitamin A status is associated with prematurity and uterine growth retardation 
found in poorly nourished populations (Shah 1984). Zinc deficiency has been 
incriminated in infertility, abortions, malformations, foetal intrauterine growth 
retardation, premature and postmature births and perinatal death. Risk groups 
for developing zinc deficiency are found among those with insufficient food 
intake, especially in protein malnutrition; abnormal mucosal uptake, as in celiac 
disease; abnormal intestinal losses, as in inflammatory bowel disease; abnormal 
renal excretion, as in diabetes with insufficient metabolic control; alcoholism; 
and treatment with diuretic drugs (Jameson 1993).
Smoking. It has been noted that babies bom  to mothers who smoke while 
pregnant have a lower birth weight than babies whose mothers do not (Zabriskie 
1963). Two possible explanations have been given for this; a) reduced food 
intake by smokers and b) anoxia. These may be the same factors involved in the 
increased risk for smokers having spontaneous abortion (Kline 1977). Smoking, 
certainly in pregnancy, tends to be correlated with alcohol intake. Writing in the 
Lancet, Harlap (1980) suggested that some studies o f smoking and spontaneous 
pregnancy loss have not considered the effects o f drinking alcohol, but taking 
this into account they still found a higher incidence o f abortion among smokers.
Alcohol. More than one quarter o f pregnant women drinking twice a week or 
more are likely to abort, compared with about 14% among women who drink 
less often (Kline 1980).
Drugs. Abuse o f illegal drugs is known to increase the incidence o f spontaneous 
abortion. It is reported that one in four Americans has used cocaine for its
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euphorigenic properties. Women in this group have an increased incidence o f 
spontaneous abortion, placental abruption and neonatal neurobehavioural 
abnormalities. There is also evidence o f increased incidence o f congenital 
malformations, intrauterine growth retardation, premature labour and sudden 
infant death syndrome for cocaine abusers (Das 1994).
Stress. Working on mice subjected to ultrasonic sound stress Arck (1994) suggests 
that stress may inhibit protective suppressor mechanisms and promote secretion 
o f abortogenic cytokines such as tum our necrosis factor alpha (tnf-a).
Toxic chemicals. Exposure o f the mother (or the father prior to pregnancy) to 
certain harmful chemicals can increase the likelihood o f spontaneous abortion. 
Hospital staff involved in sterilising procedures during their pregnancy had a 
spontaneous abortion rate o f 16.7% compared to 5.6% for non exposed 
pregnancies. The chemicals implicated were ethylene oxide and, to a lesser 
degree, gluteraldeyde. (Hemminki 1982). Anaesthetic gases are thought to be 
responsible for the increased incidence o f spontaneous abortion among hospital 
staff working in operating theatres (Vessey 1980). Other chemicals used in 
industry and in laboratories are known abortogens e.g. trypan blue stain.
Ethylene oxide, mentioned above, is used in the production o f antifreeze, floor 
varnishes and surfactants, as well as for sterilising instruments (Croner 1992).
Exposure to radiation. Women who are, or may be, pregnant are not recommended 
to undergo X-ray examination because of the risk o f abortion or birth defects. 
The human embryo-foetus is highly radiosensitive and must be protected from 
excessive exposure to ionizing radiation. The maximum permissible dose 
equivalent for the developing embryo-foetus is set at 0.5 rem per year (Caprio
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1980). Recently there has been the suggestion that exposure to the low frequency 
magnetic fields ofVDTs (visual display terminals) may be a causal factor in 
abortion (Goldhaber 1988). One study found that women working in clerical 
positions using VDTs for more than twenty hours per week had double the risk 
o f spontaneous abortion o f other women. However, professional women using 
VDTs for twenty hours or more per week were not found to have a higher risk 
than women who are nonusers, suggesting that VDT use was not the causal 
factor in clerical women. In 1991 the US government's National Institute for 
Occupational Safety and Health published details o f the largest study to date and 
concluded that women working with VDTs were at no increased risk o f 
spontaneous abortion.
Medical techniques. The removal o f a sample o f amniotic fluid to test for foetal 
abnormalities (amniocentesis) carries a 1% risk o f abortion (Medical Research 
Council 1978, Tabor 1986). Chorion villus sampling (CVS), a technique 
performed between 8 and 10 weeks gestation, which involves the sampling o f 
trophoblast (the cellular layer which gives rise to the placenta) via a needle 
through the mother's abdomen, carries a 2.9% risk o f spontaneous abortion 
(Medical Research Council European Trial 1991). Although the use o f 
ultrasound technology has greatly reduced the risk o f abortion caused by these 
procedures, they are restricted to women for whom there may be a high risk o f 
foetal abnormalities such as those over 40 years old. Ultrasound itself has been 
implicated in one study as causing spontaneous abortions in physiotherapists 
working with ultrasound as well as short-wave radiation (Taskinen 1990). While 
it is recommended that pregnant medical workers avoid unnecessary exposure to 
ultrasound the risk o f diagnostic ultrasound causing harm to the foetus has not
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been proven, though a link with repeated ultrasound diagnosis and low birth 
weight has been noted (Salvesen 1995)
Accident. Pregnancy loss following an accident, such as a fall, is extremely rare as 
the foetus is well protected in the uterus. Spontaneous abortion caused by 
trauma is unlikely unless there is a direct penetrating injury (Howie 1995).
Infection. Infection is implicated as an occasional cause o f spontaneous abortion 
(Summers 1994). Listeria monocytogenes, a food borne organism found in soft 
cheeses, can cause listeriosis, an infectious disease with influenza-like symptoms. 
Listeriosis can result in spontaneous abortion and stillbirth (Shaw 1995). 
Pregnant women are advised to avoid soft cheeses and pate. Chlamydial infection 
is a sexually transmitted bacterial infection that has been linked to spontaneous 
abortion (Tuormaa 1994).
Fever. A fever o f more than 100°F was found to be “antecedent, rather than a 
symptom o f spontaneous abortion” (Kline 1985).
1.4 Immunological factors
1.4.1 The Immune System
The body has a system o f differentiating self from nonself and, where a 
foreign molecule is detected, set up a response to deal with it (Male 1996). The 
foreign molecule, or antigen, may be a parasite, fungus, bacterium or virus. 
Reaction to an antigen is highly specific. Burnet's clonal selection theory (1958) 
states that there is a specific lymphocyte for every possible antigen. Exposure to 
an antigen leads to clonal expansion o f a specific lymphocyte and hence an
immune response.
An important feature o f the immune system is immune memory which is the 
basis o f vaccination. When an antigen to which the body has previously been 
exposed is encountered, T  cells which were activated in the initial exposure are 
still viable and a larger and quicker response can be mounted to the antigen.
1.4.2 Cells of the immune system (Lydyard 1996)
The immune system is made up o f a number of organs connected by a 
network o f vessels (figures 1.1 and 1.2). The cells o f the immune system are the 
white blood cells (figure 1.3).
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Figure 1.3 Cells o f the immune system
White blood cells may be divided into two major populations;
1. Mononuclear, or "round” cells with a single nucleus and
2. Polymorphonuclear with segmented nuclei.
Mononuclear cells are further divided into large (macrophage or monocyte) and 
small (lymphocyte).
Monocytes are formed in the bone marrow and circulate in the blood to tissues 
where they mature into macrophages. Macrophages are involved in immune 
responses, they function as scavengers but their prime function is presentation o f 
antigen. Macrophages, along with polymorphonuclear leukocytes, have an active 
role in the inflammatory response associated with immune reactions. 
Macrophages may accumulate in large numbers in sites o f inflammation, The 
migration to these sites is believed to be non-antigen specific.
Lymphocytes form 30% o f the total o f white blood cells and are the main 
constituents o f the immune system. The lymphocyte is responsible for the 
primary recognition o f  antigen and is an immunologically specific effector cell. 
Lymphocytes can be subdivided into two major populations, T  cells and B cells, 
deriving their names from the sites where the immature cells differentiate to 
their mature forms. Although morphologically very similar, T  and B 
lymphocytes have different cell surface phenotypes (each cell type o f the 
immune system has a diverse array o f surface adhesion molecules that allow 
recognition via discrete corresponding surface receptors).
T  Cells. Prothymocytes (T cell precursors) are produced in the bone marrow and 
circulate to the thymus. Thymus derived cells (T cells) originate in the thymus
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from these precursor cells and are then re-released into the circulation. T  cells 
participate in cell mediated reactions and, although they do not themselves 
produce antibodies, they help regulate antibody production by B lymphocytes (B 
cells). T  cells are divided into subpopulations according to their functions.
When activated by antigen, T  helper cells (also known as CD 4+ve because they 
display a molecule called CD4 on their surface) will produce effector molecules 
that will activate, or deactivate, other lymphocytes. These effector molecules are 
called interleukins. When cytotoxic, or killer T  cells (marked by the surface 
protein CD8 and therefore called CD8+ve) are activated by antigen they make 
direct contact with target cells and kill them by secreting toxic molecules. Other 
T  cells induce inflammation (T delayed hypersensitivity cells) and inhibit 
immune response (T suppressor cells).
T  cells are the master regulators o f the immune system, they turn other cells in 
the immune system off or on.
B Cells. These arise from precursors in the bone marrow. B cells are the 
precursors of plasma cells, the cells that synthesise immunoglobulins (Figure 
1.4). Surface immunoglobulin is readily detected on B cells, but not on T  cells. 
When activated by antigen B cells differentiate into antibody (immunoglobulin) 
secreting plasma cells. Plasma cells are found in large numbers in lymph nodes, 
spleen and sites o f chronic inflammation.
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Immunoglobulins consist o f two 'heavy' chains and two 'light' chains held 
together by inter-chain disulphide bonds (Figure 1.5). The chains have an N - 
terminal portion that forms the antigen binding site. This N-terminal varies 
according to the antigen while the rest o f the structure remains constant. There 
are five major classes o f immunoglobulins (Ig). These are IgA, IgD, IgE, IgG and 
IgM. In the bloodstream IgG is the main immunoglobulin found. The 
immunoglobulins found on the surface o f unstimulated B cells are IgM and IgD. 
When B cells are stimulated they first secrete IgM then switch to secretion o f 
IgG, IgA or IgE.
Blast Cells. These are activated cells in the process o f dividing. They are found in 
lymphoid organs draining sites o f antigen injection. They are also found in active 
inflammatory lesions. Blast cells may be induced in vitro in cultures of 
lymphocytes by certain mitogenic agents. Lymphocytes that recognise antigen are 
stimulated by that antigen to transform into blast cells. These blast cells 
proliferate and then differentiate into plasma cells or sensitised T  cells.
1.4.3 Interleukins
Interleukins are a series o f lymphocytotrophic hormones. They are a 
group o f proteins that act on the immune system in much the same way as 
hormones and their receptors act on the endocrine system. Eighteen different 
interleukins have been identified to date, though the list is sure to expand. 
Interleukins are discussed in more detail in chapter 5.
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1.5 Immunology of normal pregnancy
Although much work has been carried out in the field o f immunology of 
a normal pregnancy there is still much that is not understood. The foetus 
receives its genetic material from both parents, and as such is essentially an 
allograft. An allograft (from Greek alios meaning other) is a graft o f tissue from a 
donor to a recipient o f the same species, where the two individuals are not 
genetically identical. A normal pregnancy would thus appear to be against the 
basic principles o f transplant immunology. The body has the ability to 
differentiate self from non-self, and where foreign material is detected, initiate a 
response i.e. graft rejection (Gurka 1987). The usual mechanism o f immunologic 
rejection o f an allograft involves the presentation o f the foreign antigen to 
regional lymph nodes and processing o f the antigen by macrophages. As a result 
effector T-cells proliferate and produce antibodies and cytotoxic lymphocytes, 
then return via the bloodstream to eventually destroy the foreign graft. Rejection 
o f the foetus does not normally occur (Medawar 1953). Several theories have 
been advanced to explain the success o f the foetal allograft.
1.5.1 Protection of the foetus
There are a number o f possible mechanisms that can protect the foetus 
from rejection;
1.5.1.1 The Uterus
The uterus is not an immunologically privileged site (immuno-suppressed 
micro-environment), it is well vascularised, with gpod lymphatic drainage and
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can reject foreign tissue. Some lymphoid cells found in the uterus contain IgA, 
IgM and IgG. The uterus is therefore well supplied with immune components 
and is unlikely to protect the foetus.
1.5.1.2 The Placenta
At the placenta the maternal blood is in direct contact with the trophoblast. The 
trophoblast is the layer o f tissue formed by cells that form the outer covering o f 
the blastocyst (the spherical structure produced by cleavage o f a fertilised egg). 
The placenta forms a physical barrier to corpuscular and large molecular particles 
between the maternal and foetal blood. As well as this physical barrier the 
placenta is thought to act as an immunologic filter. The immunologic profile of 
placental tissue as described by Goldsobel et al 1986 indicates considerable 
cytotoxic activity and several unique phenotypic characteristics that differentiate 
it from either the maternal or the foetal immune system.
W hen small numbers o f maternal lymphocytes enter the foetal circulation, and 
vice versa, certain inhibitory substances could be associated with the placenta, 
causing the opposing cells to be hyporesponsive (Cadet 1995) . This 
hyporesponsiveness may be manifested by a reduced capacity for the production 
o f cytokines such as interferon gamma, interleukin ip  (IL-ip) and tumour 
necrosis factor a  (TN Fa). Cadet proposes interleukin 10 (IL-10) as such an 
inhibitory substance and has found that the placenta does indeed express IL-10 
messenger RNA. Human placental cell lines are also found to produce IL-10. IL- 
10 has been shown to inhibit the synthesis o f interferon gamma, granulocyte- 
monocyte stimulating factor, IL-1, IL-2, IL-3 and T N F a It also plays a role in 
the neuroendocrine system as an inducer o f ACTH, which upregulates the
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production o f adrenal glucocortosteroids which are immunosuppresive. All 
foetal trophoblast populations throughout gestation express high levels o f cell 
surface complement regulatory proteins, providing protection from 
complement-mediated damage at the matemo-foetal interface (Vince 1995). 
Restricted antigen presentation has also been suggested as an explanation o f 
foetal survival (Wood 1994).
Around the time o f implantation and during early pregnancy the human uterine 
mucosa is infiltrated by large numbers o f CD56+ve natural killer (NK) cells. 
Approximately 80% o f maternal leukocytes present in human decidua at this 
time are CD56+ve N K  cells (King 1996). These leukocytes are in close 
proximity to the foetally-derived invading extravillous trophoblast which 
expresses at least two HLA class I molecules, HLA-G and HLA-C (Verma 1997). 
The specific expression o f HLA-G in placental trophoblast suggests an important 
role for this molecule in the immunological interaction between mother and 
child (Miinz 1997). It is thought that maternal recognition o f the foetus may be 
mediated by an N K allorecognition system (Hiby 1997) and that N K  inhibition 
by HLA-G may contribute to the survival o f the foetal semiallograft in the 
mother during pregnancy.
Wegmann (1988) came to the conclusion that maternal T  cells, rather than being 
potentially detrimental to the foetal allograft, promote its growth and viability 
during normal pregnancy. T  cells could be activated by placental trophoblast and 
produce cytokines that make trophoblast grow better. T-Helper cells are sub 
divided into T H1 and T H2 cells (Wegmann, 1993). T H1 cells secrete 11-2, IFN-y 
and TN F-p. These are cytokines that are deleterious to pregnancy, possibly by 
inducing N K  cell activity. T H2 cells produce cytokines that are beneficial to
pregnancy, such as 11-3,11-4,11-5 and 11-10. These cytokines are involved in 13- 
cell production. 11-10 inhibits T H1 cells and so a bias away from cell mediated 
immunity towards antibody-associated immunity is proposed. Possible evidence 
o f this lies in the fact that a majority o f patients with rheumatoid arthritis, a cell 
mediated autoimmune condition, enjoy a remission o f disease symptoms during 
pregnancy, while patients with systemic lupus erythematosis (SLE), a condition 
o f excess auto-antibodies may experience a flare up o f disease symptoms whilst 
pregnant. In vitro experiments show that peripheral blood mononuclear cells 
from women respond to trophoblast antigens with a dichotomous T-helper 
response (Hill, 1995). These experiments show that “trophoblast cells induce a 
T H2-type cytokine response that may benefit pregnancy, whereas many women 
with unexplained recurrent pregnancy loss manifest an abnormal T Hl-type 
response following exposure to trophoblast extracts”.
1.5.2 Autoimmunity
Autoimmunity is the process by which a humoral or cellular response is 
directed against a specific component o f the host. Examples o f autoimmune 
diseases are systemic lupus erythematosus (lupus), progressive systemic 
scleroderma, polymyositis, dermatomyotis, mixed connective tissue disease, 
autoimmune thyroid disease, multiple sclerosis and 'sub clinical autoimmune 
disease.' Autoantibodies are often found in the blood o f older people with no 
symptom o f disease, thus a great deal o f the degeneration o f our bodies as we age 
may be due to sub clinical autoimmune disease. Some autoimmune diseases 
affect women much more than men. Rheumatoid arthritis is 2-3 times more 
frequent in females, and lupus 6-10 times more, than found in males. In these
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diseases which predominantly affect women, there is a tendency for the disease 
to appear in the childbearing years, leading to speculation that women are more 
prone than men because they have developed more powerful immune systems in 
connection with their childbearing function (Clark 1995). That such 
autoimmune diseases are influenced by sex hormones is shown by experiments 
on lupus prone FI hybrid mice (Jacobson et al 1994). The antibodies most 
prominently found in lupus are to DNA, and are in fact diagnostic for the 
disease. Castrated male and female mice were injected with gonadotropin 
releasing hormone (GnRH) agonists and antagonists. GnRH antagonist 
administration significantly decreased total serum immunoglobulin G and anti- 
DNA antibodies in castrated male and female mice and significantly improved 
survival. In contrast, GnRH agonist administration exerted reciprocal effects in 
castrated mice, leading to early increases in serum anti-DNA and total 
immunoglobulin G levels.
In spontaneous abortion the most striking autoimmune association is with the 
presence o f antiphospholipid antibodies, lupus anticoagulant and anticardiolipin 
(Silver 1994). The mechanism o f pregnancy loss where these antibodies are 
present is decidual or placental insufficiency, related to the thrombotic tendency 
among these patients rather than an immunologic attack on the foetus. Some 
success in avoiding vascular abnormalities in these patients is achieved by 
treatment with corticosteroids and low dose aspirin (100 mg/day).
1.5.3 Thyroid Antibodies
The thyroid autoantibodies anti thyroglobulin (anti Tg) and anti thyroid 
peroxidase (anti TPO) have been implicated as important factors in miscarriage
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by Stagnaro-Green et al (1990). In that study thyroid autoantibody positive 
women miscarried at a rate o f 17% compared with 8.4% for thyroid autoantibody 
negative women. The presence o f these autoantibodies may be useful clinical 
markers for increased risk o f spontaneous abortion. The relationship between 
thyroid autoantibodies and abortion is thought to reflect a generalised activation 
o f the immune system. Anti thyroid antibodies are organ specific, but are 
increasingly reported in similar distribution patterns to some o f the most typical 
non-organ specific autoantibodies. A substantial number o f patients with 
systemic lupus erythematosus (45%) have thyroid antibody abnormalities (Pratt 
1992). Thyroid antibodies are also implicated in reproductive failure. They are 
found in at least one third o f patients with autoimmune induced premature 
ovarian failure and it is therefore not surprising that they have now been 
associated with pregnancy loss.
1.5.4 HLA Antigens
Histocompatibility (HLA) antigens are proteins found on the cell 
surface. Every cell in the body o f an individual will have the same HLA antigens 
on the surface, marking the cell as belonging to that individual. Two different 
individuals will have different HLA antigens. The immune system is sensitive to 
differences in histocompatibility antigens and will mount a rejection response 
against HLA antigens that are not self.
Sharing 2 or more HLA (A,B,DR,DQ) antigens was found to be significantly 
more frequent in recurrent spontaneous abortion couples than in controls 
(McIntyre et al 1983, MuellerEckhardt et al 1994). Other studies have failed to 
confirm the benefit o f genetic heterogeneity to maintain human pregnancy
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(Balasch 1989, Bellingard 1995) and testing o f couples for HLA sharing is not 
recommended routinely in the evaluation o f recurrent abortion (Coulam 
1992).The foetus inherits half o f its genetic material from the father and this has 
led to the hypothesis that increases in HLA compatibility between mother and 
foetus are in some way linked to a deficiency in the development o f anti-foetal 
antibody during pregnancy. As a consequence, the foetus may be deprived o f the 
protection by maternal blocking antibody, which may allow maternal cytotoxic 
reactions to cause abortion (Unander et al 1983).
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1.6 Treatment Regimes for Abortion
Table 1.1 is reproduced from Scott (1994) and summarises his 
recommendations for an efficient and cost effective diagnostic workup in 
patients with recurrent miscarriage.
Suggested Routine Evaluation for Recurrent Pregnancy Loss*
History
Pattern and trimester of pregnancy losses and whether a live embryo or foetus was
present
Exposure to environmental toxins or drugs
Known gynaecologic or obstetric infections
Features associated with antiphospholipid syndrome
Genetic relationship between partners
Family history of recurrent miscarriage or syndrome associated with embryonic or foetal
loss
Gynaecologic or menstrual disorders
Previous diagnostic tests and treatments
Physical
General physical examination—habitus, galactorrhea, hirsutism, stigmata of endocrine
disorders
Examination of vagina, cervix and uterus for normal discharge, findings suggestive of
diethystilbestrol exposure or uterine abnormalities
Tests
Hypersalpingogram
Luteal phase endometrial biopsy; repeat in next cycle if abnormal
Parental karyotypes
Lupus anticoagulant and anticardiolipin antibodies
Other laboratory tests only if suggested by history and physical examination
* Ultrasound examination at 6 weeks’ gestation in next pregnancy and chromosome analysis ot 
products of conception from any subsequent miscarriage
Table 1.1. Diagnostic workup in patients with recurrent miscarriage
James R. Scott (1994)
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Most embryos from first trimester spontaneous abortions are chromosomally or 
morphologically abnormal (Scott 1994). Treatable maternal or paternal factors 
are therefor not involved in most cases o f spontaneous abortion. Despite the 
expense, Scott recommends parental chromosome analysis to complete a 
thorough evaluation for recurrent abortion. Treatment o f parental chromosome 
abnormalities is limited to explanation, donor egg, donor sperm or adoption but 
advances in reproductive technologies may hold out hope for this problem in the 
future.
Recurrent miscarriage is a distressing condition, the causes o f which are still not 
fully understood. As a result o f this, only limited help is available for women 
with this condition. Current therapies on offer include the following:
1.6.1 hCG
Human Chorionic Gonadotrophin (hCG) Therapy
In many cases where tests have not given a conclusive reason for recurrent 
miscarriage a course o f hCG is given from first confirmation o f pregnancy until 
about fourteen weeks. Some centres (Quenby 1994) claim to have success rates 
o f 86% where the patients suffered from oligpmenorrhea (from Greek oligo 
meaning little), a reduction in the frequency o f menstruation with cycles usually 
exceeding 40 days, compared to a 40% success for such patients taking placebo. 
H CG  therapy for patients with normal periods had a success rate o f around 85% 
but the placebo group also had 85% success. Others remain sceptical about the 
effectiveness o f this treatment.
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1.6.2 Immunotherapy
As indicated in chapter one, the concept o f an allo-immune cause of 
recurrent abortion remains a contentious matter. Despite the lack o f  specific data 
to support the hypothesis o f allo-immune abortion, many centres have attempted 
to immunise mothers with either paternal or third party leukocytes in the hope 
that this will induce the appropriate immune response and protect the foetus 
from rejection (Mowbray 1985, H o 1991). A marginal benefit from 
immunotherapy has been reported but this must be weighed against the potential 
complications o f the treatment. Hepatitis (infective and autoimmune), 
anaphylactic shock, virus transmission and transfusion reactions have all been 
reported (Mowbray 1994).
1.6.3 Corticosteroids, anti-coagulants and aspirin
Systemic lupus erythematosis is an autoimmune disease which causes 
joint pains and can affect internal organs. Ten percent o f the 30,000 women in 
UK with lupus also have antiphospholipid syndrome (APS), a disorder which 
makes blood sticky (Lima 1996). Blood clots can form in the placenta o f these 
women and destroy areas o f the placenta, thus causing a miscarriage. It is now 
thought that antiphospholipid antibodies have an adverse effect on embryonic 
implantation (Rai 1996). Success with anticoagulant (heparin or warfarin), 
antiplatelet (dipyridamole) and low dose aspirin has caused some doctors to call 
for APS screening after one miscarriage.
Other centres have suggested a treatment regime o f glucocorticosteroids, 
anticoagulants and platelet inhibitor therapy for patients with APS associated
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with lupus anticoagulant and a poor obstetric history (Menashe 1993). The use 
o f steroids in pregnancy, however, has been reported as being detrimental and 
associated with a significant excess o f pre-term deliveries and pre-eclampsia 
(Cowchock 1992, Silver 1993).
1.6.4 Surgical Intervention
Cervical incompetence is cited as a cause for, mainly second trimester, 
abortion. Congenital malformations o f the uterus are associated with recurrent 
pregnancy loss. After surgical correction there is a pregnancy success rate o f 
about 70 to 90% (Scott 1989). O ther workers believe that cervical incompetence 
is over-diagnosed and recommend careful evaluation o f this syndrome before 
cervical cerclage is carried out (Rai 1996).
1.6.5 Psychological Support
As early as 1940 psychotherapy was deemed necessary as part o f therapy 
to prevent repeated pregnancy loss (Javert 1940). This psychotherapy consisted 
o f ‘reassurance, the creation o f a strong bond o f confidence in and dependency 
on the physician and repeated suggestions that the pregnancy would succeed’. 
Post psychotherapy a miscarriage rate o f 7.5% was reported, compared to a rate 
o f  79% before therapy (Javert 1954). Other workers reported similar success 
using psychotherapy (Mann 1959). One study (Stray-Pederson 1988) evaluated 
the effect o f ‘tender loving care’ in 116 women. Tender loving care was defined 
as psychologic support along wdth weekly medical and ultrasound examinations. 
Successful pregnancy outcome was reported in 85% o f the women who received 
tender loving care compared to only 36% o f women who did not participate in
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the study.
Although none o f these studies were properly designed to evaluate the role o f 
supportive psychotherapy (Keye 1994), reports o f patients treated in this way 
suggest that supportive therapy is important to reduce the anxiety and distress 
felt by these women. Special clinics, usually found in large teaching hospitals, 
dedicated to patients with recurrent pregnancy loss offer supportive therapy, as 
well as investigate the cause o f miscarriage. Unfortunately there are not many 
clinics o f  this type in the U K
Finally it is important for clinicians, when assessing the efficacy o f treatment 
given to patients with recurrent abortion, to remember that even without 
treatment about 60% o f these women will be successful in their next pregnancy 
(Regan). Control groups in trials o f various treatments for recurrent pregnancy 
loss have varied from 29% to 76% (Coulam 1992).This spontaneous cure rate, 
while holding out hope for patients, can be an obstacle for workers looking for 
funding for research into recurrent abortion.
1.7 Normal Menstruation and Pregnancy
In order to study and understand what goes wrong in a pregnancy to 
result in miscarriage it is first necessary to look at normal pregnancy. What 
follows is a brief description o f normal menstruation and pregnancy along with 
definitions used in the thesis (de Gruyter 1988).
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1.7.1 The Menstrual Cycle
The menstrual cycle is the time from day one o f menstruation till the 
day before the next period. The duration o f the menstrual cycle is, on average 
29.5 days, with large variations between women. However, individuals show 
some constancy in cycle duration. The cycle, which is under hormonal control, 
can be divided into four phases:
day 1-4 menstruation
day 5-12 follicular development
day 12-17 intermenstruum, ovulation occurs
day 17-28 luteal phase
Menstruation (from the Latin menstruum monthly flow) is the monthly shedding 
o f the endometrium that occurs throughout the reproductive life from menarche 
(Greek menos month; arche beginning) to menopause. True menstruation 
occurs only when a corpus luteum has formed in an ovary in the previous cycle 
following ovulation. Where there has been no fertilisation and nidation 
(embedding o f a fertilised ovum into the endometrium) the production o f 
ovarian hormones from the degenerating corpus luteum decreases. The 
endometrium need no longer be maintained and is shed. This is the 
desquamation phase or menstruation per se (Figure 1.6).
Follicular development (Figure 1.7). The follicle develops from a primary follicle 
50/Am in diameter to a mature Graaf s follicle which is 20mm in diameter.
Follicle stimulating hormone (FSH) stimulates oestrogen production in the 
mature follicle o f  the ovary which itself stimulates the proliferation o f the 
endometrium. There is a sharp rise in FSH and Luteinizing hormone (LH) on
approximately day 12 o f the cycle. This can occur earlier or later and it is the 
length o f time o f this proliferation phase that determines the length o f the cycle, 
the secretory phase which follows ovulation being fixed at 14 days (Ojeda 1992).
Ovulation. The mature Graaf s follicle ruptures with the expulsion o f the mature 
ovum into the fallopian tube.
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Figure 1.7 Follicular developm ent
Luteal phase. U nder the influence o f LH, and later luteotropic hormone (LTH) 
(prolactin), the corpus luteum produces progesterone. Progesterone transforms 
the endometrium into the secretory phase. Levels o f progesterone in blood rise 
from around l,500pg/ml in the follicular phase to 3,000-20,OOOpgfail in the luteal 
phase (Figure 1.8).
Follicle stimulating hormone (FSH). A gonadotropin produced by the anterior 
pituitary lobe (APL). Release from the APL is controlled by FSH-releasing 
hormone (this is probably identical to luteinizing hormone releasing hormone 
LH-RH). FSH promotes granulosa cell growth in Graaf s follicle, glycolysis and 
amino acid uptake in the ovary and plays a central role in the regulation o f the 
menstrual cycle.
Luteinizing hormone (LH). A gonadotropin o f molecular weight 28,000 which 
consists o f two amino acid chains (a and b) the a-chain, being identical to the a- 
chains o f  HCG, FSH and TSH, contains 89 amino acids. The b-chain, which 
consists o f 115 amino acids, is responsible for the biological action and also has 
an immunogenic action. LH induces follicular maturation and ovulation and 
brings about the development and function o f the corpus luteum (and hence the 
synthesis o f oestrogens and progesterone) Secretion o f LH is controlled by 
luteinizing hormone releasing hormone (LH-RH), a decapeptide produced by 
the hypothalamus. LH-RH also stimulates the release o f FSH.
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Figure 1.8 Hormone levels in menstrual cycle
1.7.2 Pregnancy
Pregnancy occurs as a result o f the fertilisation o f an ovum by sperm. 
With fertilisation cell division begins, and the fertilised egg develops into a mass 
o f cells called the morula that move through the fallopian tube into the uterus. 
The morula continues to divide until it becomes a hollow clump o f about a 
hundred cells called the blastocyst. About seven or eight days after fertilisation, 
the blastocyst settles on the wall o f the uterus (nidation). Some o f the cells 
covering the blastocyst, known as the trophoblast, begin to eat into the lining o f 
the uterus and anchor the blastocyst to the wall o f the uterus (Figure 1.9). The 
trophoblast eventually develops into the placenta.
The blastocyst is composed o f two layers, the upper, ectoderm layer, and the 
lower, endoderm layer. An amniotic cavity and yolk sac soon appear in the 
blastocyst. The amnion lines the chorion, the outermost envelope that furnishes 
a protective and nutritive covering for the zygote, as the fertilised egg is now 
called. The embryonic disk, a flat area in the cleaved ovum in which the first 
traces o f the embryo are seen, is suspended from the chorion and is composed o f 
three germ layers, the ectoderm, mesoderm, and endoderm. All organs o f the 
embryo are developed from these three germ layers.
From the ectoderm the nervous system, sense organs, and epidermis, among 
others, are developed. The circulatory, excretory, skeletal, muscular, and 
reproductive systems are developed from the mesoderm. The endoderm 
produces the respiratory and digestive systems, along with their linings.
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Figure 1.9 Pregnancy
O n average, a normal pregnancy lasts for 38 weeks from conception till birth. As 
conception occurs midway through the menstrual cycle, just after ovulation, and 
on a date that is not known exactly, doctors calculate pregnancy from the first 
day o f the last menstrual period. Therefore the average pregnancy is said to last 
40 weeks. Pregnancy is divided into three, approximately equal, trimesters. It is 
in the first trimester, when the various organs o f the foetus are formed, that 
miscarriage is most likely to occur. During the second and third trimesters the 
foetus develops and matures until full term i.e. between 38 and 42 weeks.
Parity. This is defined in the Concise Oxford Dictionary as the fact or condition 
o f having borne children, or the number o f children previously borne. A 
primigravida is a woman who is pregnant for the first time. Doctors represent 
this as 0+° i.e. zero (0) live births and zero (°) pregnancies that did not continue 
beyond 28 weeks. 3 + 1 represents a multigravid woman who has borne three 
children and has also had one miscarriage.
1.8 Free Radicals, Antioxidants and Reactive Oxygen 
Species
Free radicals have recently been implicated as having a role in 
spontaneous abortion (Sane 1991).
A free radical is any chemical species (atom or molecule) capable o f independent 
existence that contains one or more unpaired electrons in their outermost 
orbitals. Electrons are more stable when paired together in orbitals and therefore 
radicals are, on the whole, more reactive than non-radical species (Halliwell 
1989). When two radicals meet they can combine their unpaired electrons and
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join to form a covalent bond. An unpaired electron is represented as (*).
A* + A* -»  A-A
A radical might donate its unpaired electron to another molecule or steal from 
another in order to pair. However in doing this the other molecule itself 
becomes a radical, and so a feature o f the reactions o f free radicals is that they 
proceed as chain reactions.
Free radical mechanisms can have both beneficial and detrimental actions in vivo. 
Such mechanisms play a fundamental role in many physiological reactions such 
as mitochondrial oxidation, oxygen transportation by haemoglobin and 
cytochrome P450 activity.
At a cellular level the innate high reactivity o f free radicals can cause cellular 
oxidative damage. When tissue is exposed to high level radiation, such as gamma 
radiation, most o f the energy taken up is absorbed by the cell water. The 
radiation causes one o f the oxygen-hydrogen covalent bonds in water to split, 
leaving a single electron on hydrogen and one on oxygen, thus creating two 
radicals.
H -O -H  + radiation —> H* +  *O H
H* is the hydrogen radical, *O H  is the hydroxyl radical.
Oxygen, which has two unpaired electrons in separate orbitals acts as a free 
radical. Oxygen is required to transform various substances for the release o f 
energy, to oxidise endogenous compounds and to detoxify xenobiotics 
(compounds not occurring in nature, especially synthetic organic compounds
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that are recalcitrant to biodegeneration) (Sinclair 1990). Oxygen acts as a 
terminal 4-electron acceptor and is eventually converted to water. The reduction 
o f oxygen is frequently incomplete and a series o f reactive chemical 
intermediates are produced. These intermediates are hydrogen peroxide, the
superoxide radical (O*)  and the hydroxyl radical (OH*) (figure 1.10).
The hydroxyl radical is the most reactive radical species known to chemistry and 
can attack and damage almost every molecule found in living cells. 
Polyunsaturated fatty acids, proteins, DNA and carbohydrates are all susceptible 
to free radical damage particularly from the hydroxyl radical.
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Figure 1.10 Electron reduction o f oxygen
Lipid peroxidation is a free radical chain reaction stimulated by the hydroxyl 
radical (*OH). This occurs when the *O H  is generated close to cell membranes 
and attacks the fatty acid side chains o f the membrane phospholipids. The *O H  
pulls off an atom o f hydrogen from one o f the carbon atoms in the side chain 
and combines to form water.
Lipid peroxidation causes a reduction in membrane fluidity and permeability. 
The reactions can be halted by the action o f free radical-scavenging molecules 
such as vitamin E or vitamin C. These molecules produce more stable radical 
derivatives (Porter 1984). The chain reactions which result from lipid 
peroxidation can cause injuries at sites distant from the original site o f free 
radical generation.
When the hydroxyl radical attacks DNA, free radical chain reactions propagate 
through the DNA and cause chemical alterations o f the bases or deoxyribose 
sugars. This can lead to mutations and strand breakage. Imperfect repair o f such 
damage can lead to oncogene activation and carcinogenesis. Paradoxically, 
hydroxyl radical generation is the major mechanism by which malignant cells are 
destroyed during radiotherapy.
Mammalian DNA has evolved in such a way as to offer protection from free 
radical damage. Nuclear DNA is compartmentalised away from mitochondria 
and peroxisomes where most radicals are probably generated and most non­
replicating nuclear DNA is surrounded by histones which may have a protective 
role against free radical attack.
Free radical induced damage to proteins may result in fragmentation, cross- 
linking, aggregation of protein and the induction o f autofluorescence. This
41
damage can be manifested by an inactivation o f certain enzymes or indeed 
activation o f enzymes by inactivation o f the relevant inhibitor. Extracellular 
proteins with a large proportion o f disulphide bridges such as IgG or albumin 
appear to be particularly susceptible to hydroxyl and peroxy radical attack.
Free radical production is required for host protection from bacterial invasion, 
but once formed free radicals can cause tissue damage (McCord 1985). 
Production o f free radicals may be increased during various disease states such as 
inflammation and during metabolic conditions such as hypoxia and tissue 
ischaemia (Dormandy 1983).
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1.8.1 Sources of free radicals in biological systems
Table 1.2 shows the two main sources o f free radicals: cellular and 
environmental.
Source Examples
Cellular metabolism Prostaglandin synthesis 
Mitochondrial electron transport 
Endoplasmic reticulum oxidation
Enzymic activity 
Oxyhaemoglobin
NADPH oxidase 
Xanthine oxidase
Auto-oxidation Adrenalin 
Melanin thiols 
Reduced riboflavin 
Flavin
f m n h 2
Flavin adenine 
dinucleotide
f a d h 2
Environmental Drugs Halothane
Paracetamol
Cytotoxics Bleomycin
Doxorubicin
Pesticides
Photochemical air pollutants 
Tobacco smoke
Paraquat
Radiation X-ray water radiolysis 
Light Photoionisation 
Photoexcitation 
o f organic molecules
Table 1.2. Sources o f Free Radicals in  Biological Systems
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1.8.2 Anti-oxidant systems
To protect themselves from the effects o f free radicals aerobic organisms 
have developed antioxidant systems. These take the form o f enzymes such as 
superoxide dismutase (SOD) and low molecular weight free radical scavengers 
such as vitamin E. These limit the cellular concentrations o f free radicals and 
prevent excessive oxidative damage (oxidative stress).
1.8.3 Detection of free radicals
Free radicals are highly reactive and consequently have a life span o f 
microseconds or less and as such can only be detected in flagrante by the use o f 
electron-spin resonance (ESR) spectroscopy (Dormandy 1989). An electron 
occupying an orbital by itself can choose its direction o f spin. ESR measures the 
energy changes that occur when they change their direction o f spin.
Detection o f free radicals by an indirect approach is more common in the 
biological laboratory. While free radicals themselves are undetectable, some 
products o f free radical mediated reactions are relatively stable. These products 
serve as markers o f free radical activity.
1.8.4 Superoxide Dismutase
The enzyme superoxide dismutase was discovered in 1938 (Mann and 
Klein), though its biological activity as a catalyst o f dismutation was not 
described until 1968 (McCord & Fridovich). They demonstrated that 
erythrocyprein (superoxide dismutase) catalysed the dismutation o f superoxide
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radicals generated during the reduction o f cytochrome C.
2 0 2 + 2 H + “ > H 20 2 + 0 2
Misra and Fridovich developed an assay based on the photo-oxidation o f 
dianisidine sensitized by riboflavin. This involved a complex series o f chain 
reactions with the SOD ion as a chain propagating species. They proposed that 
the mechanism o f photo-oxidation o f O-dianisidine involves the following 
reactions;
Rb + hv —> Rb* (a)
Rb* + D H 2 -> RbH* + DH* (b)
RbH* + 0 2 -»Rb + 0 2' + H + (c)
DH* + 0 2" + H + -> DH2 -1- 0 2 (d)
DH* + DH* -* D + D H 2 (e)
Oo + Oo + 2H + SOD 5 H , 0 ,  +  O 0 (0
D H 2 is O-dianisidine Rb is Riboflavin
D is the product formed by photo-oxidation and is measured at 460nm.
In reaction (a) riboflavin absorbs a photon and becomes electronically excited. In 
reaction (b) the excited riboflavin oxidises dianisidine, yielding a flavin 
semiquinone and a dianisidine radical which, in the absence o f competing 
reactions, would dismute as in reaction (e) to yield oxidised dianisidine which 
absorbs at 460nm. However, the flavin semiquinone produced (in reaction b)
can reduce 0 2 to 0 2_ (reaction c) and the 0 2" can in turn reduce the dianisidine 
radical (reaction d). SOD which scavenges the 0 2~ (reaction f) would thus
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prevent the reaction (d) relative to reaction (e). Thus in the presence o f SOD an 
increase in absorbance will be observed.
1.8.5 Caeruloplasmin
Caeruloplasmin (Cp) is a blue copper protein that accounts for 90% of 
total plasma copper. Copper is incorporated into caeruloplasmin at the time o f 
synthesis in the liver. There are 6 or 7 copper atoms bound to each molecule o f 
Cp. Cp has a small thiol (SH) titre o f less than 0.5 SH /  mole but extra thiol (1 to 
4 groups per mole, depending on what technique is used) appears on removing 
the copper from the reduced protein using chelating agents, suggesting that the 
metal is bound to thiol groups. Cp oxidises Fe2+ to Fe3+ which can bind to 
transferrin (Dormandy 1978). This has the effect o f  inhibiting iron-dependant 
and copper-dependant lipid peroxidation.
1.9 Aims of study
The aims o f this study were:
1. To evaluate free radical scavenger levels in different phases o f the normal 
menstrual cycle and compared to levels in males.
Interest in the role o f free radicals in inflammation and tissue destruction 
has increased in recent years. One aim o f this study was to see if  free radical 
scavenger levels, and therefore free radical levels, altered at different phases o f 
the normal menstrual cycle or if indeed free radical levels in males differed to 
those o f non pregnant women measured at various phases o f their menstrual 
cycle. Measured in the study were two extracellular (plasma thiols and
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caeruloplasmin) and two intracellular (lysate thiol and superoxide dismutase) 
components o f the antioxidant system.
2. To investigate some immunological aspects o f miscarriage:
Free radical scavengers, thyroid antibodies, mitogen stimulation and 
antibody production by lymphocytes and cytokine levels.
The study examined whether free radical scavenger levels in women admitted to 
hospital undergping, or following, a spontaneous abortion differed from those in 
healthy pregnant women.
As discussed earlier, the anti thyroid antibodies, anti-thyroglobulin and anti­
thyroid peroxidase, have been identified as useful clinical markers for increased 
risk o f spontaneous abortion by Stagnaro-Green et al (1990). For this study 
samples were assayed to detect thyroid antibody levels in normal pregnant and 
aborting women to see if  a relationship could be found between antibody levels 
and pregnancy loss.
Other immunologic characteristics o f miscarriage were looked at for this study. 
Mitogen stimulation and antibody production o f lymphocytes in tissue culture 
and estimation o f cytokine levels in sera from pregnant, non pregnant, 
spontaneous aborters and recurrent aborters were assayed. The aim was to form 
an overall impression o f the immunological changes occurring in pregnancy and 
abortion and see if  particular immunological abnormalities are associated with 
abortion.
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Chapter Two
Methods
2.1 Stimulation of Lymphocytes
2.1.1 Tissue culture reagents
Foetal calf serum was supplied by Northumbria Biologicals Ltd., 
Cramlington, U K  The same batch o f serum was used throughout the study.
Phosphate buffered saline (PBS) tablets from Qxoid Ltd., U K  were reconstituted 
according to manufacturers instructions.
Lymphoprep was obtained from Nyegaard, Oslo Norway.
Thymidine was supplied by Gibco BRL Ltd., U K
Stock thymidine solution. A 5 mM solution was prepeared by dissolving 121mg o f 
thymidine in 100ml PBS This was filter sterilised and stored at 4°C.
thymidine (TRK 418, specific activity 40-60 Ci/mM) was supplied by 
Amersham International pic, U K
Working thymidine solution. This was prepared by mixing 500 /xCi 
thymidine (0.5 ml o f lm C i/m l) with 0.1 ml o f stock thymidine solution and 
made up to 10 ml in RPMI.
R P M I1640 from Gibco BRL, UK was supplied at lQx concentration and was 
diluted prior to use as follows:
Sterile distilled water (431.5 ml).
RPMI 1640 10X (50ml).
Sodium bicarbonate (13.5ml).
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Penicillin (10,000 U/ml) and Streptomycin (lOmg/ml) (5ml). 
L-glutamine 200mM from Gibco BRL Cat N o 25030 (5ml).
N aO H  solution (6M) was added dropwise to bring to neutral pH.
White cell diluting fluid. A few crystals o f crystal violet were added to 1% acetic acid 
in PBS.
Phytohaemagglutinin (PHA). Sigma Cat. no. L9132. A whole vial (5mg) was 
resuspended in 5 ml o f  sterile distilled water (1000 /xg/ml). This was stored at - 
20°C in 50 x 100 /xl aliquots. Before use one aliquot was thawed and made up to 
10 ml in RPMI to give a working dilution o f 10 /xg/ml.
Concanavalin A  (Con A). Sigma Cat no. C2010. A whole vial (25mg) was 
resuspended in 5 ml o f sterile distilled water (5 mg'ml). This was stored at -20°C 
in 50 x 100 /xl aliquots. Before use one aliquot was thawed and made up to 5 ml 
in RPMI to give a working dilution o f 100 /xg/ml.
Pokeweed mitogen (PWM) for the mitogen stimulation assay. Sigma Cat. no. L9379. A 
whole vial (5mg) was suspended in 100 ml o f RPMI (50 /xgfail). This was stored 
at -20°C in 20 x 5ml aliquots. One 5ml aliquot was divided into 50 small aliquots 
o f 100 /xl each. These were also stored at -20°C. Before use one small aliquot was 
thawed and made up to 25 ml in RPMI to give a working dilution o f 0.2 fig/ml.
Pokeweed mitogen for the B-cell stimulation assay. This was obtained from Gibco 
BRL, Life technologies Ltd., PO Box 35, Trident House, Renfrew Rd., Paisley 
PA3 4EF Cat. no. 061-05360B. This was resuspended in sterile PBS and stored at 
-20°C in aliquots of220/xl. Prior to use one aliquot was thawed and 200/xl was 
added to 9.8 ml o f RPMI. This gives a 1:50 dilution. An aliquot (3ml) o f this was
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added to 12 ml o f RPMI to give a working dilution o f  1:250.
2.1.2 Lymphocyte separation
Details o f this method are described in Boyum A. (1968) (Figure 2.1). 
Heparinised venous blood was aseptically added to an equal volume o f RPMI 
1640. Diluted blood (5ml) was floated onto Lymphoprep (5ml) in sterile 15ml 
plastic conical tubes. The tubes were spun at 1200 RPM for 30 minutes. The 
lymphocytes settle in a dense white band in the centre o f the tube. These were 
removed with a Pasteur pipette and washed three times with PBS. After the last 
wash the pellet o f cells was resuspended in 2 ml RPMI. To count the cells 10pl 
o f the suspension was diluted 1/10 in white cell diluting fluid and counted on a 
haemocytometer. The number of cells per ml was calculated and then diluted in 
RPMI 1640 to give final working dilutions o f 106 per ml for 
phytohaemagglutinin and concanavalin A and 2xl06 per ml for pokeweed 
mitogen.
mu
Whole
blood
+
RPMI
5ml /
Lymphocytes
Lymphoprep
red
blood
cells5ml
Figure 2.1. Ficoll-Hypaque separation o f lymphocytes
51
2.1.3 Mitogen stimulation
To minimise variation, all mitogens used were taken from the same 
batch throughout the study, and were prepared as described above. Assays were 
carried out in 96-well sterile plates (Greiner UK Ltd.).
RPMI (lOOpl) for a control (C) and 100 fi\ o f mitogens diluted as described 
previously were added to appropriate wells. Cells were made up in RPMI 
containing 20% human serum to a concentration o f 106/ml for C, PHA and Con 
A and at 2 x 106/m l for PWM. Cell suspensions (lOOpl) were added to 
appropriate wells.
Plates were incubated for 68 hours at 37°C in a humidified atmosphere o f 5 % 
C 0 2 /  air. After the incubation 20 [A o f 3H  thymidine (made up as previously 
described ) was added to each well. The plate was then returned to the incubator 
for 4 hours. After the incubation the contents o f the plates were harvested using 
a Packard Micromate 196 harvester. The harvester removed cells by a vacuum
onto disks on fibre filter mats (Packard). Unbound passed through into a 
reservoir. The filters were washed, then dried in a microwave oven for 2 minutes 
before being counted in a Packard Matrix 96 direct beta counter. Triplicate 
means were calculated and results were expressed as a stimulation index (SI) ie
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SI (PHA) =  total counts PHA - total counts control 
total counts control
SI (Con A) =  total counts Con A - total counts control 
total counts control
SI (PWM) = total counts PWM - total counts control 
total counts control
2.1.4 Immunoglobulin production
This method is described in Wilson (1988). Assays were carried out in 
24-well sterile plates from Greiner Ltd. All cultures were set up in duplicate and 
there was a total volume o f 2ml per well. Control wells contained 1ml cells at a 
concentration o f 106 per ml and 1ml o f 20% foetal calf serum (FCS) in RPMI (ie 
a total cell concentration o f 5x10s per ml). Pokeweed mitogen at a concentration 
o f 1:250 was added to test wells in duplicate, the concentration o f FCS and cell 
numbers being the same as in the control wells. The controls were set up to 
account for spontaneous release o f immunoglobulins. The plate was incubated 
for 7 days at 37°C in a humidified atmosphere o f 5 % C 0 2 /  Air. After 
incubation the media were pipetted off and the duplicates pooled in 15ml conical 
tubes. The tubes were spun at 700G for ten minutes, after which the 
supernatants were taken off and stored in a -20°C freezer until they were assayed.
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2.1.5 Immunoglobulin ELISA reagents
IgG and /IgM standards. Frozen aliquots o f standard were stored at -70°C 
and thawed immediately prior to use. 8 p\ o f standard in 20ml o f diluting buffer 
gave a concentration o f400 ng/ml. From this serial dilutions were made to give 
standards o f200,150,100, 75, 50,25 and 10 ng/ml.
Coating buffer. This was prepared by mixing 2.2mls 0.2M Na2C 0 3 solution 
(2.12g/100ml) with 2.8mls 0.2M N aH C 0 3 (1.68g/100ml) and making up to 
lOOmls with deionised water.
Anti-Human IgG (g-chain specific). Sigma Cat. No. 1-7883
Anti-Human IgM (m-chain specific). Sigma Cat. No. 1-8633.
Immunoglobulin standards. IgG (Cat. No. 1-4506) and IgM (Cat. No. 1-8260) were 
obtained from from Sigma Ltd.
Alkaline Phosphatase Conjugate. Anti-human IgG (Cat. No. A-3150) and Anti­
human IgM (Cat. No. A-3275) were obtained from Sigma Ltd.
Substrate buffer. This was prepared by mixing 2.2mls 0.2M Na2 C 0 3 
solution(2.12g/100ml), 2.8mls 0.2M N aH C 0 3 solution(1.68g/100ml) and 2.0mls 
0.01M MgC12 solution(0.95g^l00ml) and making up to 20mls with deionised 
water.
Diluting (blocking) buffer. This was prepared by dissolving bovine serum albumin 
(5g) and sodium azide (0.5g) in 11 o f PBS.
Washing buffer. This was prepared by dissolving bovine serum albumin (5g),
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sodium azide (0.5g) and 0.5ml Triton X I00 (or Tween 20) in 11 o f PBS.
Quality control material. Using samples from previous studies, a pool o f 
supernatants with high immunoglobulin content was made.
2.1.6 ELISA for estimation of IgG and IgM
This method was described by Wilson et al (1989). The inter assay 
coefficient o f variation was calculated for this study by running Q C samples with 
each assay and was found to be 14.6% for IgG and 22.4% for IgM.
Pre-coating Plates. Flexible plates (96-well) from Greiner were used. Goat anti­
human IgG or IgM (200/xl) (10/xl/10ml coating buffer) was added to each well 
with two wells left empty to estimate non specific binding. The plate was 
incubated at 37°C for 1 hour, then washed 4 times with wash buffer. After 
blotting the plate dry, 200/xl blocking buffer was added to each well, and the plate 
stored at 4°C. The plate was stored at this stage for up to 2 months.
Standards (100/xl), quality control samples and samples were added in duplicate 
to designated wells. An aliquot (100/xl) o f the highest concentration standard 
(400ng/ml) was added to the non specific binding well. The plate was incubated 
for 2 hours at 37°C. After the incubation the plate was washed 4 times and 
blotted dry on paper towel.
Anti-human IgG/IgM (10/xl) conjugate (0.6 mg conjugate/ml) was diluted in 
10ml o f diluting buffer, o f this Diluted conjugate (100 /xl) was added to each 
well. The plate was incubated for 2 hours at 37°C. After the incubation the plate 
was washed 4 times and blotted dry on paper towel.
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P-nitrophenyl phosphate (PNP) substrate (100 /xl) (Sigma) (lmg/ml in substrate 
buffer) was added to each well. The plate was incubated for 30 minutes at 37°C. 
After the incubation the reaction was stopped by the addition o f 100 fil o f 3M 
N aO H  to each well.
Optical density was measured at 410 nm on a Dynatech MR700 microplate 
reader. The plate was zeroed using the non-specific binding well.
A calibration curve was constructed by plotting optical density o f at 410 nm 
against standard concentration. Test samples were then read off from this curve.
For quality control purposes aliquots from the Q C pool were assayed 20 times to 
estimate intra-assay variation. The pool o f samples was then split into aliquots o f 
300/Ltl and stored at -20°C. These were used as Q C samples and were run with 
each assay. A Q C  profile was made up and results were only accepted if  Q C  was 
within 2 standard deviations o f the mean.
2.2 Free Radical Estimations
Free radical methods were based on those described by Ellman (1959), 
Menden (1977) and Misra (1977)
2.2.1 Reagents
PBS  was prepared from tablets supplied by Sigma and kept at 4°C.
Chloroform:ethanol 3:5. A mixture o f chloroform (90ml) and ethanol (150ml) was 
prepared and stored at -20°C.
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Sodium phosphate buffer (0. 1M). This was prepared as follows:
Two solutions were prepared:
Solution A . 8.89g Na2H P 0 4 . 2 H O  in 500mls deionised water (pH 9.5). 
Solution B. 7.80g N aH 2P 0 4 .2H20  in 500mls deionised water (pH 4.5). 
All o f solution A was used with solution B added dropwise until the pH  
was 7.6. The buffer was stored at 4°C for up to 2 weeks.
D TN B  (0.01M). A0.01M solution o f 5,5’ dithiobis-(2-nitrobenzoic 
acid)(DTNB) in 0.1M Na2H P 0 4 at pH  7.6 was made up and kept on ice and 
used within 1 hour o f preparation.
Sodium acetate buffer (1.195 M) for Caeruloplasmin assay. Sodium acetate (24.5g) 
was dissolved in 250 ml H 20  and the pH  was adjusted to 5.4 by the addition o f
glacial acetic acid. This buffer was stored for up to 2 weeks at 4°C.
p-Phenylenediamine (PPD) solution (9.25mM) for Caeruloplasmin assay. 
p-Phenylenediamine (0.050g) was dissolved in 50mls sodium acetate buffer in a 
beaker covered in tin foil to protect the solution from light. The solution was 
kept on ice and used within 1 hour o f  preparation.
Sodium azide solution (3mM) for Caeruloplasmin assay. Sodium azide (0.0487g) 
was dissolved in 250 mis o f distilled H 20 .  This solution was freshly prepared for
each assay and was kept on ice.
0.01 M  potassium phosphate buffer pH  7.5. This was prepared as follows:
Solution A: KH2 P 0 4 (molecular weight 136.1) 0.68g/500ml 
Solution B: K2 H P 0 4 (molecular weight 174.2) 0.87g/500ml
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All o f solution B (the alkali salt) was used and solution A was added dropwise to 
bring down the pH  to 7.5.
Riboflavin solution i.3xi0~^- This solution was made up freshly for each assay and 
as riboflavin is light sensitive, was kept in a beaker covered with aluminium foil. 
Because o f the small amount o f chemical to be weighed, this solution was made 
up at lQx strength then diluted ie riboflavin (0.005g) was made up in lOOmls o f 
phosphate buffer then 10 mis o f this was made up to lOOmls in phosphate buffer.
O-dianisidine solution (0.01M). This solution was made up freshly for each assay. 
O-dianisidine (0.061g) was dissolved (after a lot o f mixing) in ethanol (25mls) 
and kept in a universal container covered in foil.
Superoxide dismutase standards. Superoxide dismutase from Sigma Product number 
S2515, activity 3,000 units per mg. This was kept in -20°C freezer. SOD was 
reconstituted in phosphate buffer and a new set o f standards were made up every 
four weeks. These were kept at 4°C.
Plasma and lysate Quality Control materials. This was prepared from pools o f lysate 
or plasma samples and stored in small aliquots at -70°C. A Q C  sample was run 
with each assay.
2.2.2 Specimen preparation
Heparinised blood (10 ml) was stored at 4°C for a maximum of 24 hours 
before assay. The blood was spun for 10 minutes at 3000 rpm and 4°C. The 
plasma was removed and stored at 4°C. The packed red cells were washed twice
58
with phosphate buffered saline. Washed red cells (1 ml) were incubated with an 
equal volume o f distilled H zO  for 2 hours at 4°C. Haemoglobin was precipitated
out o f these lysed cells by the addition o f 800 /xl o f chloroform : ethanol 3:5 (v/v) 
per 2 ml lysed cell solution. This produced a brick red paste which was kept on 
ice for 10 minutes and mixed occasionally by stirring with a glass rod. After the 
incubation 3 drops o f chloroform : ethanol and 300 /xl distilled H zO  were added, 
and again the paste was mixed with the glass rod. The sample was spun for 10 
minutes at 3000 rpm and 4°C. The pale yellow/clear supernatant was removed 
and lysate thiol and superoxide dismutase activity were assessed.
2.2.3 Plasma and lysate thiol levels
Thiol levels in plasma (PSH) and lysate (LSH) were determined by the 
method o f Ellman (1959). The basis for the analysis is the thiol disulphide 
interchange reaction between 5,5’ dithiobis-(2-nitrobenzoic acid) (ESSE) and 
biological thiols.
ESSE + RSH <-> ESSR + ESH
At pH  7.6 ESH is ionised to ES", a colourless species with bond maximum at 412 
nm which can be used to determine thiol concentration.
An array o f tubes was set up in a rack at room temperature. The assay is 
summarised in the table 2.1. All samples were assayed in duplicate.
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Na2 H PO 4 Sample DTNB
buffer (mis) (plasma/lysate) 0*1)
A blank 3.0
B reagent blank 2.5 500
C plasma blank 2.8 200
D plasma test 2.3 200 500
E lysate blank 2.8 200
F lysate test 2.3 200 500
Table 2.1. Summary o f thiol determination in plasma and lysate
The D TN B buffer was added to tubes at timed intervals (30 seconds) and 
absorbance was measured (440nm) against respective blanks after 5 minutes. The 
value for the reagent blank was subtracted from the sample test values.
PSH Intra assay precision (cv = 1.2%) was calculated by running 20 samples o f 
plasma from the same heparinised blood sample in one assay.
LSH Intra assay precision (cv = 16.7%) was calculated by assaying 20 different 
lysates from one heparinised blood sample in one batch.
LSH Inter assay precision (cv =  7.9%) was calculated by assaying aliquots of 
lysate made for Q C  sample with each assay.
2.2.4 Plasma Caeruloplasmin Assay
Caeruloplasmin oxidase activity was measured by the method of 
Menden (1977). The method is based on the caeruloplasmin catalysed oxidation
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o f p-phenylenediamine to Bandrowski’s base (figure 2.2).
p-phenylenediamine Bandrowski’s Base
Figure 2.2. Bandrowski’s base
Plasma was separated from whole blood in lithium heparin bottle. This was kept 
at 4°C for a maximum of 7 days prior to assay.
Plastic conical tubes (15ml) were set up in a rack on ice. Three tubes per sample 
were labelled, one for a blank and two test samples. Plasma samples were 
removed from the fridge prior to assay and allowed to reach room temperature. 
Plasma (50/d) was added to each tube then sodium azide solution (5ml) was 
added to blank tubes only. P-phenylenediamine solution (1ml) was then added 
to all tubes and the rack was shaken by hand before being incubated in a shaking 
water bath at 37°C. The rack was taken out o f the bath after exactly 15 minutes 
and placed on ice. Sodium azide solution (5ml) was added to all test samples (not 
the blanks) to stop the reaction. The rack was dipped in the water bath to allow 
the tubes to return to room temperature. The absorbance o f each test sample was 
read against its blank at 525nm on a Pye Unicam SP8-400 spectrophotometer. 
This measurement o f Bandrowski’s base at 525nm serves as the basis for defining 
the molecular activity o f caeruloplasmin. Activity was converted to concentration
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by referring to a calibration curve using known concentrations o f purified 
human caeruloplasmin. This curve cuts the x  and y  axes at zero, the gradient o f 
the line is y = 0.00526 x.
Results are expressed as units m g'! 00ml.
The intra assay %cv was calculated by running 20 plasma samples from the same 
whole blood in one assay and was found to be 3.8%. The inter assay %cv was 
calculated by assaying an aliquot o f frozen pooled plasma and was found to be 
22.5%. Previous studies stated that Cp was only stable for 7 days at 4°C and this 
high inter assay %cv may be indicative o f Cp instability.
2.2.5 Lysate Superoxide Dismutase assay
This method is based on the increase in rate o f photo-oxidation o f O - 
dianisidine sensitized by riboflavin and was described by Mizra and Fridovitch 
(1977). The measurement was carried out on lysate samples prepared as 
described above.
A specially constructed light box was required for this assay. This consisted o f a 
wooden, foil lined box with a door. Inside the box were two Philips fluorescent 
bulbs (8w) placed 6” apart. In the centre was an upturned beaker onto which 
cuvettes were placed. The box was 38cm high and had a base measuring 648cm^.
O n the day o f the assay the samples and standards were removed from the fridge 
and allowed to reach room temperature. The spectrophotometer (Pye Unicam 
SP8-400) was switched on and the wavelength adjusted to 460nm. Quartz 
cuvettes (3ml) were covered with foil and the light box was switched on.
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Riboflavin solution was added to each o f 4 cuvettes (2.94ml for first cuvette 
(blank) and 2.88ml for the rest). Standard or lysate sample (60/xl) was added to all 
but the blank cuvette. O-dianisidine solution (60/xl) was added to all cuvettes 
each now containing a total volume o f 3mls. The cuvettes were inverted to mix 
the sample, then the foil was removed and the absorbance o f each was measured 
at 460nm. The samples were illuminated for exactly 4 minutes each then 
removed from the light box and the absorbance was again read at 460nm. This 
procedure was continued, in groups o f 4 cuvettes at a time till all standards and 
samples had been assayed.
The difference in absorption between illuminated and baseline samples was 
calculated and a standard curve was plotted. Unknown samples were read off 
from this plot. A quality control sample was run with each assay.
Results were multiplied by a correction factor (78.125) and expressed as /xmol/L.
The intra assay %cv was 9.2% and the inter assay %cv was 39.5% This very high 
inter assay variation may be due to SOD degrading in freezer during prolonged 
storage.
2.3 Cytokines
2.3.1 Human Interleukin 1(3 (hulL1(3)
This was measured using an ELISA kit from the Central Laboratory of 
the Netherlands Red Cross Blood Transfusion Service. The kit is specific for 
bioactive huILip and recognises natural and recombinant IL ip  equivalently. 
There is no detectable cross reactivity for recombinant mouse ILip, recombinant
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human IL la , recombinant mouse IL la , recombinant human IL2, recombinant 
human IL3, recombinant human IL4, recombinant human IL6, IL7, IL8 and 
recombinant human M-CSF, recombinant human GM-CSF and recombinant 
human T N F a.
Because o f the expense, not enough kits were run to calculate an “in house” %cv. 
The inter assay coefficient o f variation quoted by the manufacturer was 8.8%.
The kit is a "sandwich-type" o f enzyme immunoassay in which a monoclonal 
anti-human IL1(3 antibody has been pre-coated to polystyrene microtitre wells. 
Human IL1(3, present in a measured volume o f standard or sample is bound by 
the antibody on the microtitre plate. Non-bound material is then removed by 
washing. Subsequently a rabbit antibody to huILip is added. This binds to the 
huILip-antibody complex present in the microtitre well. Excess o f the rabbit 
antibody is removed by washing, followed by addition o f horseradish peroxidase 
(HRP) conjugated gpat-anti-rabbit antibody, which binds onto the rabbit side o f 
the huIL ip sandwich. After removal o f non-bound HRP conjugate by washing, 
substrate solution is added to the wells. A blue coloured product is formed in 
proportion to the amount o f IL ip  present in the standard or sample. After the 
reaction has been stopped absorbance is measured in a microtitre plate reader. 
From the absorbance o f samples and those o f a standard curve, the concentration 
o f IL ip  can be determined by interpolation with the standard curve.
Six standards (500, 250, 100, 50,10 and 0 pg/ml ) were supplied lyophilised and 
had to be reconstituted prior to use in serum diluent. A standard or serum 
sample (100 /xl) was added to designated wells, leaving one well empty as a blank.
The plate was gently tapped for 15 seconds, then covered and incubated for 2
64
hours at 37°C.
After the incubation the plate was washed 4 times, then blotted dry on paper 
towel. Anti- IL1{3 (100 /xl) was added to all but the blank well. The covered plate 
was incubated for 1 hour at 37°C.
After the incubation the plate was washed 4 times, then blotted dry on paper 
towel. HRP-conjugated Goat anti-rabbit antibody (100/xl) was added to all but 
the blank well. The covered plate was incubated for 30 minutes at 37°C.
After the incubation the plate was washed 4 times, then blotted dry on paper 
towel. Substrate solution (100 /xl) was added to all wells, including the blank. 
The plate was incubated for 15 minutes at room temperature, in the dark.
The reaction was stopped by addition o f concentrated H 2 SC>4 (100 /xl). The 
plate was read at 450 nm on a Dynatech M R 700 microplate reader.
A calibration curve was constructed by plotting optical density at 450 nm against 
huILip concentration in pg/ml on log-linear paper. The best fitting curve was 
drawn and test sample values were then read off from this curve.
2.3.2 Interleukin 2 Receptor (IL2-R) ELISA
This was measured using an enzyme immunoassay for the quantitative 
determination o f IL2-R supplied by T  Cell Diagnostics, Inc. The manufacturer’s 
quoted assay sensitivity was 50U/ml. Because o f the expense, not enough kits 
were run to calculate an “in house” %cv. The inter assay coefficient o f variation 
quoted by the manufacturer was 4.8-5.6%. Intra assay variation was 2.2-3.4%.
A 96 well plate was pre-coated with murine monoclonal antibody to IL2-R.
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IL2-R standard and sample serums (50 /xl) were added to wells in duplicate.
Horseradish Peroxidase conjugated murine monoclonal antibody to human IL2- 
R (100/xl) was added to all but blank wells. The plate was agitated by tapping for 
15 seconds, then sealed and incubated at room temperature on a rotator at 150 
RPM.
The plate was then aspirated and washed with a buffer o f 0.1% surfactant in PBS 
This step was repeated another 2 times, then the plate was blotted on paper 
towel.
Chromogen solution, containing O-Phenylenediamine, (100/xl) was added to all 
wells and the uncovered plate was incubated at room temperature for 30 
minutes.
Stopping solution (2N H 2 SO4) (50/xl ) was added to all wells.
The optical density was obtained for each well by reading the plate in the 
Dynatech M R 700 plate reader at 490nm.
A standard curve was generated by plotting the optical densities (at 490nm) for 
the standards versus their concentrations. The best curve was drawn (log/linear) 
and unknown patient samples were read off from this.
2.3.3 Interleukin 6 (IL6) ELISA
An enzyme immunoassay for the quantitative determination o f IL6 was 
supplied by Eurogenetics. The manufacturer’s quoted assay sensitivity was 
5p^m l. Because o f the expense, not enough kits were run to calculate an “in 
house” %cv. The inter assay coefficient o f variation quoted by the
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manufacturer was 3.8-8.7%. Intra assay variation was 5.5-9.4%.
2.3.3.1 Supplementary reagents
The following solutions for the assay and were made up in advance: 
Coating buffer. Carbonate/Bicarbonate buffer (0.1M) at pH  9.6.
PBS stock solution. Phosphate Buffered Saline (0.2M) at pH  6.8-6.9.
PBS working strength buffer. Phosphate Buffered Saline (0.01M) at pH  12-1 A. 
Blocking buffer. Supplied blocking reagent (500/d) in 25ml working strength PBS. 
Washing buffer. PBS (0.01M) with 0.005% TWEEN 20.
Dilution buffer. This was supplied 5x concentrated with kit and diluted to working 
strength in distilled water
Substrate buffer. Acetate buffer (0.11M) at pH  5.5.
TMB Stock Solution. 6mg/ml 3,5,3,5’-tetramethylbenzidine in dimethylsulfoxide
Hydrogen peroxide solution. Hydrogen peroxide (3%) in distilled water.
Substrate solution. This was prepared by mixing substrate buffer (2ml) with TMB 
stock solution (200/xl) and hydrogen peroxide solution (12/xl).
Stop solution. 1.8M Sulphuric Acid
2.3.3.2 Assay procedure
Monoclonal antibody to IL6 (120/xl) was diluted in coating buffer
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(12ml). 100/xl was added to each well o f a 96 well plate and then incubated at 
room temperature overnight.
Supernatants were aspirated from all wells and the wells were washed 5 times 
with working strength PBS. The plate was blotted on paper towel.
Blocking buffer (100/xl) was added to all wells. The plate was incubated at room 
temperature for 1 hour.
The plate was aspirated and washed 5 times in washing buffer, then blotted dry 
on paper towel. 100/xl standards prepared in dilution buffer and serum samples 
diluted 1:2 in dilution buffer were added, in duplicate, to wells, leaving 2 wells 
empty as blanks.
The plate was incubated at room temperature for 1 hour, then aspirated and 
washed 5 times in washing buffer and blotted dry on paper towel.
Biotinylated 11-6 antibody (100/xl) was added to all but blank wells.
The plate was incubated at room temperature for 1 hour, then aspirated and 
washed 5 times in washing buffer and blotted dry on paper towel.
Streptavidin-HRP conjugate (100/xl) was added to all but the blank wells and the 
plate was incubated for 30 minutes at room temperature.
The plate was washed 5 times in washing buffer and blotted dry on paper towel.
Substrate solution (100/xl) was added to all wells and the plate was incubated at 
room temperature, in the dark for 30 minutes.
Stop solution (100/xl) was added to all wells. The optical density was obtained for
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each well by reading the plate in the Dynatech M R 700 plate reader at 450nm.
A standard curve was generated by plotting the optical densities (at 450nm) for 
the standards versus their concentrations. The best curve was drawn (log/linear) 
and unknown patient samples were read off from this.
2.3.4 ELISA For Interleukin 8 (IL8)
This assay was performed with IL8 kit from Amersham International pic, 
Amersham, (UK) (Kit code no. RPN  2147).
This assay employs the quantitative immunometric, "sandwich” enzyme 
immunoassay technique.
Because o f the expense, not enough kits were run to calculate an “in house” %cv. 
The inter assay coefficient o f variation quoted by the manufacturer was 12.2%. 
The intra assay coefficient o f variation was 9.2%.
A 96 well plate was pre-coated with a monoclonal antibody specific for IL8. IL8 
standard was supplied lyophilised and was reconstituted prior to use. This was at 
a concentration o f 6000 pg/ml. Serial dilutions were carried out to give standards 
o f3000,1500, 750,375,187.5 and 93.8 pg/ml.
Substrate solution was supplied as solutions A and B. These were mixed 
immediately prior to use.
Assay diluent (100 /xl) was added to each well. Standard or serum sample (100 /A) 
was added to each well. After gentle tapping for 1 minute, the plate was covered 
and incubated for 2 hours at room temperature.
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After the incubation the plate was washed 4 times with wash buffer then blotted 
dry on paper towel.
IL8 conjugate (200 /xl) was added to each well. The plate was then re-covered 
and incubated for 2 hours at room temperature.
After the incubation the plate was washed 4 times with wash buffer then blotted 
dry on paper towel. Substrate solution (200 /xl) was added to each well. The plate 
was kept at room temperature and after 20 minutes the reaction was stopped by 
addition o f stop solution (50/xl).
The optical density was obtained for each well by reading the plate in the 
Dynatech MR 700 plate reader at 450 nm. A standard curve was generated by 
plotting the optical densities (at 450nm) for the standards versus their 
concentrations. The best curve was drawn and unknown patient samples were 
read off from this.
2.4 Thyroid Antibodies
2.4.1 ELISA for Autoantibodies to Thyroglobulin
This was measured with an ELISA kit from RSR Ltd, Cardiff, UK. A 96 
well plate was pre-coated with purified thyroglobulin. Positive control serum 
and patient samples were diluted 1:20. Standards, controls and diluted samples 
(50/xl) were added in duplicate to appropriate wells and the covered plate was 
incubated on a plate shaker for 30 minutes at room temperature. After the 
incubation the plate was washed 4 times with diluted wash solution, then blotted 
dry on paper towel. Protein A-phosphatase conjugate solution (100/xl) was
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added to each well. The covered plate was incubated on a plate shaker for 30 
minutes at room temperature. After the incubation the plate was washed 4 times 
( 2 times with diluted wash solution and 2 times with distilled water), then 
blotted dry on paper towel. Substrate solution (100/xl) (containing 1 mg/ml 
PNPP in substrate buffer) was added to each well and the plate was incubated 
for 15 minutes in the dark. After this a yellow-green colour developed and the 
reaction was stopped by adding 1M N aO H  (100/xl). Optical density was 
measured at 405nm on a Dynatech MR 700 microplate reader. A calibration 
curve was constructed by plotting optical density at 405nm against antibody 
concentration. Test sample values were then read off from this curve.
2.4.2 ELISA for Autoantibodies to Thyroid Peroxidase (anti TPO)
This was measured with an ELISA kit from RSR Ltd, Cardiff, UK. A 96 
well plate was pre-coated with purified thyroglobulin-free TPO  Positive control 
serum and patient samples were diluted 1:20. Standards, controls and diluted 
samples (50/xl) were added in duplicate to appropriate wells and the covered 
plate was incubated on a plate shaker for 30 minutes at room temperature. After 
the incubation the plate was washed 4 times with diluted wash solution, then 
blotted dry on paper towel. Protein A-phosphatase conjugate solution (100/xl) 
was added to each well. The covered plate was incubated on a plate shaker for 30 
minutes at room temperature. After incubation, the plate was washed 4 times (2  
times with diluted wash solution and 2 times with distilled water), then blotted 
dry on paper towel. Substrate solution (100/xl) (containing lmg/ml PNPP in 
substrate buffer) was added to each well and the plate was incubated for 15 
minutes in the dark. After this a yellow-green colour developed and the reaction
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was stopped by adding 1M N aO H  (100/xl ). Optical density was measured at 
405nm on a Dynatech MR 700 microplate reader. A calibration curve was 
constructed by plotting optical density at 405nm against antibody concentration. 
Test sample values were then read off from this curve.
2.5 Subject Population
The following groups were included in the study.
Non pregnant females
Samples were obtained from women, not on the oral contraceptive pill, with a 
mean menstrual cycle o f 28 ± 3 day duration. The women were aged 29.4 ±4.5 
years. The following subgroups were looked at;
Follicular phase (day 5-9)
Luteal phase (day 18-22)
Ovulating (day 14)
Menstruating
Normal males
These healthy male volunteers were not taking any medication and were aged
30.5 ± 6.3 years.
Pregnant
Samples from women in the first trimester o f pregnancy were assayed. The 
women were aged 27.2 ± 5.5 years.
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Aborters
Samples were taken from women admitted to hospital suffering a spontaneous 
abortion in the first trimester o f pregnancy. The women were aged 27.5 ± 5.8 
years. Blood was taken from these women prior to them going to theatre. They 
were grouped as follows;
First pregnancy aborters (primary aborters)
First time aborters with previous successful pregnancy (secondary 
aborters)
Women aborting for the second time
Women aborting three or more times (recurrent aborters)
O f the 22 first pregnancy aborters 13 were resampled at a three months follow- 
up visit and 9 were resampled in a subsequent pregnancy.
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Chapter Three
Lymphocyte Proliferation
and Function
3.1 Tissue Culture
This chapter concerns the setting up into cell culture o f isolated 
peripheral blood lymphocyte cells from various patient groups. Maintaining cells 
in culture (in vitro), according to the methods described in chapter two, provides 
a system whereby we can stimulate cells and extrapolate from their behaviour to 
what may happen in vivo, within the body.
3.1.1 Cell Proliferation
The technique used involves the centrifugation o f a suspension o f whole 
blood (diluted 1:1 with RPMI) on Ficoll-Hypaque (Lymphoprep) gradients 
(Boyum 1968). Ficoll-Hypaque is an aqueous solution o f density 1.077 
containing Ficoll 400, a high molecular weight polymer and diatrizoate sodium, 
which has high density and low viscosity. In this separation system red blood 
cells and granulocytes aggregate in the presence o f Ficoll, which increases their 
sedimentation rate, and they therefore settle at the bottom of the centrifuge tube. 
Lymphocytes and other mono-nuclear cells remain at the interface o f the plasma 
and the Ficoll-Hypaque due to their lower density. The cells from this interface 
are removed, washed in saline then set up in culture at known concentrations.
Autoradiography is the method used in the detection o f cell proliferation (Sigal 
1985). A constant amount o f labelled DNA precursor, ^H  thymidine, is added to 
cells growing in medium. The ^H  thymidine is then incorporated into the 
replicating DNA of the cells. The uptake o f  ^ H  correlates with the number of 
cells in the S phase o f the cell cycle. After incubation with ^H  thymidine an
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automated cell harvesting machine aspirates the cells onto glass fibre filters. The 
filters retain DNA with incorporated isotope since the cells are broken up on the 
filters and unincorporated isotope is washed away. Proliferation o f cells grown in 
a control medium is compared to cells stimulated by mitogens.
3.1.2 Lymphocyte Activation (Mitogenesis)
Lymphocyte transformation assays are used to assess the responsiveness 
o f lymphocytes. Stimulants used in lymphocyte transformation may be specific 
(antigens) or non specific (mitogens). The discovery, by Nowell (1960), that 
plant lectins such as phytohaemagglutanin (PHA) are mitogenic for lymphocytes 
began the understanding o f T  cell growth. Mitogens (e.g. lectins) activate 
lymphocytes via receptors apparently distinct from antigen recognition receptors 
(Fudenberg 1971) and cause non specific transformation o f 60 to 90% o f the total 
lymphocyte population, depending on the agent used.
The activation o f lymphocytes by lectins in vitro provides us with a means of 
assessing the responsiveness o f the lymphocyte population. Lectins are proteins, 
or glycoproteins, o f non immune origin whose precise physiological role in 
nature is unknown.
Phytohaemagglutinin (PHA) is a T  helper/inducer (CD4+ve) cell mitogen. It is 
a lectin which is an extract o f Phaseolus vulgaris, the red kidney bean (Nowell 
1976).
Concanavalin A (ConA) is a T  cytotoxic/suppresser (CD8+ve) cell mitogen. It is 
a lectin extracted from Conavalia ensiformis, the jack bean.
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Pokeweed mitogen (PWM) is a T  cell dependent, B cell mitogen. This means it 
will activate B cells only in the presence o f T  cells. PWM is a lectin extracted 
from the roots o f Phytolacca americana, American pokeweed.
Because o f the predominance o f T  cells in blood T  cell mitogens are the most 
utilised in the laboratory.
3.1.3 B Cell Function
The measurement o f immunoglobulin (Ig) production in vitro allows us 
to assess B cell function. Pokeweed mitogen (PWM) is used to trigger Ig 
production. PWM stimulates a small proportion (around 1%) o f B cells to 
secrete Ig (Sigal 1985). The amount o f Ig secreted into culture medium after a 
seven day incubation is quantified using enzyme-linked immunoabsorbant assays 
(ELISA) for immunoglobulin G (IgG) and immunoglobulin M  (IgM). Ig 
concentration in supernatants from medium containing stimulated cells is 
compared with the concentration in medium from unstimulated, control cells 
incubated under twin conditions. A stimulation index (S.I.) is calculated i.e.
SI = concentration IgG in stimulated cells -  concentration IgG in control cells
concentration IgG in control cells 
An absence o f response with PWM stimulation would suggest a lack o f B cell
function.
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3.2. Mitogenesis
3.2.1 Subject Population
Non pregnant females (Group 1). Samples were obtained from women, not 
on the oral contraceptive pill, with a mean menstrual cycle o f 28 plus or minus 3 
days duration. The samples were obtained from 19 women at the following 
stages o f their menstrual cycle;
5 follicular phase (day 5-9)
3 luteal phase (day 18-22)
5 ovulating (day 14)
6 menstruating
Pregnant (Group 2). A total o f 7 samples from women in the first trimester of 
pregnancy were assayed. O f these 3 were from primigravada women and 4 were 
from women who had been seen at the start o f this study when admitted to 
hospital suffering a spontaneous abortion, but these samples taken in a 
subsequent pregnancy.
Aborters (Group 3). A total o f 18 samples were taken from women admitted to 
hospital suffering a spontaneous abortion. They were grouped as follows;
10 first pregnancy aborters (primary aborters)
5 first time aborters with previous successful pregnancy (secondary 
aborters)
3 women aborting for the second time
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For the purpose o f statistics, analysis was carried out on the following groups;
18 all aborters
15 first aborters (with or without previous pregnancy)
O f the 10 first pregnancy aborters 6 were sampled at a 3 months follow up visit 
and 4 were sampled in a following pregnancy.
3.2.2 Results
Patient lymphocytes were stimulated by mitogens and incubated 
according to the method in chapter two. Incorporated 3H  thymidine in 
stimulated cells is compared to control cells. Results are expressed as a 
stimulation index (S.I.), calculated as follows:
c.p.m stimulated cells - c.p.m control cells 
S I. = _____________________________________
c.p.m control cells
where c.p.m. =  counts per minute
A stimulation index was chosen as the best way to express results where there is a 
wide variation in incorporation o f 3H  thymidine into control cells within and 
across all groups. Comparison o f radioactive counts only fails to recognise this 
range o f starting point.
3.2.2.1 Inter-cycle variation S.I.
Because o f the small group numbers (n=3) it was impossible to predict
the distribution o f the data and therefore a non parametric statistical analysis 
(Mann Whitney) was carried out. A p value o f <0.05 was considered significant.
ConA PHA PWM
S.I. mean sd mean sd mean sd
follicular n =  5 105.3 66.0 227.9 208.1 84.1 50.8
luteal n =  3 110.0 79.3 147.1 149.7 55.8 44.6
day 14 n =  6 59.1 85.2 96.9 92.6 43.5 58.1
menstruating n = 5 41.7 30.6 170 249.0 46.4 47.5
Table 3.1. Inter cycle Variation M itogen Srimulation Indexes
There were no statistical differences found between any phase o f the menstrual 
cycle for any o f the parameters measured. There was, however, a wide range o f 
response to the various stimulants, as seen in the following box and whiskers 
plots which show minimum, maximum, inter-quartile and median values for 
each group.
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Figure 3.1. Box and Whisker plot; M itogen Stim ulation Indexes
M enstrual Cycle; a, ConA; b, PHA; c, PWM.
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3.2.2.2 Non Pregnant v Pregnant S.I.
There was no statistical difference between stimulation indexes from 
pregnant and non pregnant samples for any o f the mitogens added.
ConA PHA PWM
S.I. mean sd mean sd mean sd
N on pregnant n =  19 74.7 68.9 158.7 175.8 56.9 50.3
Pregnant n= 7 52.5 43.2 82.5 55.7 26.17 16.77
Table 3.2. N on pregnant v Pregnant M itogen Stim ulation Indexes
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Figure 3.2. Box and Whisker plot; M itogen Stim ulation 
Indexes, N on Pregnant v Pregnant; a, ConA; 
b, PHA; c, PWM.
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3.2.2.3 Non pregnant v Abortion S.l.
There was no statistical difference between stimulation indexes o f any of 
the mitogens added between the non pregnant group and any abortion subgroup.
C onA PHA PWM
S.I. mean sd mean sd mean sd
non pregnant n=19 74.7 68.9 158.7 175.8 56.9 50.3
1st abortion n =10 
primary aborter
41.5 33.8 131.6 137.9 31.1 34.8
1st abortion n = 5  
secondary aborter
26.6 23.5 80.5 139.9 44.94 20.48
1st abortion n=15 36.53 30.72 114.6 135.8 35.71 30.70
2nd abortion n= 3 49.5 27.3 156.1 44.0 33.67 15.92
abortion n=18 38.69 29.83 121.5 125.2 35.37 28.40
Table 3.3. N on pregnant v Abortion M itogen Stim ulation Indexes
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Box and Whisker plot; M itogen Stim ulation Indexes, N on
Pregnant v Abortion; a, ConA; b, PHA; c, PWM.
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3.2.2.4 Pregnancy v Abortion S.l.
There was no statistical difference between stimulation indexes o f any o f 
the mitogens added between the pregnant group and any abortion subgroup.
ConA PHA PWM
S.I. mean sd mean sd mean sd
Pregnant n= 7 52.5 43.2 82.5 55.7 26.17 16.77
1st abortion n=  10 primary 
aborter
41.5 33.8 131.6 137.9 31.1 34.8
1st abortion n=5 
secondary aborter
26.6 23.5 80.5 139.9 44.94 20.48
1st abortion n=15 36.53 30.72 114.6 135.8 35.71 30.70
2nd abortion n=3 49.5 27.3 156.1 44.0 33.67 15.92
abortion n=18 38.69 29.83 121.5 125.2 35.37 28.40
Table 3.4. Pregnant v Abortion M itogen Stim ulation Indexes
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3.2.2.5 Abortion
There was no significant difference detected in mitogen stimulation 
index between any o f the abortion sub groups for any o f the mitogens.
3.2.3 Discussion
Previous work on mitogen stimulation has shown conflicting results. 
Sumiyoshi et al (1981) found that a reduced response to PHA occurred in 
pregnancy. MacLean et al (1992) found that the ability o f lymphocytes to 
respond to stimulation with PWM, PHA or ConA was significantly higher 
throughout pregnancy. This present study has found there to be no significant 
difference in lymphocytes response to mitogen stimulation between non 
pregnant and pregnant subjects. The reasons for this difference are unclear. 
Numbers o f patients involved may be a factor, as the numbers were relatively 
small in this study compared to those o f MacLean et al.
Lymphocytes response to mitogen stimulation was not found to fluctuate 
throughout the course o f the menstrual cycle in this study.
The various sub groups o f abortion could not be separated by their lymphocyte 
response to stimulation. This may be in partly attributable to small numbers in 
this study. Although no statistical differences were found, wide variations were 
obtained in how patients’ lymphocytes responded to mitogenic stimulation. It 
may be that the mechanism responsible for miscarriage differs between patients 
in the one group.
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3.3 B Cell Function: Immunoglobulin production
3.3.1 Subject Population
Normal non-pregnant females (Group 1). Samples were obtained from 
women, not on the oral contraceptive pill, with a mean menstrual cycle o f  28 
plus or minus 3 days duration. The samples were obtained from 48 women at 
the following stages o f their menstrual cycle;
10 follicular phase (day 5-9)
16 luteal phase (day 18-22)
14 ovulating (day 14)
8 menstruating
Normal Pregnancy (Group 2). A total of 29 samples from women in the first 
trimester o f pregnancy were assayed. O f these 10 were from primigravida 
women, 2 were from women with a history o f infertility, 6 were from women 
with a history o f successful pregnancy outcome and 2 were from women who 
had suffered a miscarriage previous to this study (one o f these patients also had a 
previous successful pregnancy). The remaining 9 samples were from women 
who had been seen at the start o f this study when admitted to hospital suffering a 
spontaneous abortion, but these samples taken in a following pregnancy. For 
statistical analysis this group o f 9 women were also treated as a sub group.
Aborters (Group 3). A total o f 49 samples were taken from women admitted to 
hospital suffering a spontaneous abortion, with blood samples taken prior to 
surgery. They were grouped as follows;
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26 first pregnancy aborters (primary aborters)
11 first time aborters with previous successful pregnancy (secondary 
aborters)
10 women aborting for the second time 
1 woman aborting for the third time 
1 woman aborting for the fourth time.
For the purpose o f  statistics, analysis was carried out on the following groups;
49 all aborters
37 first aborters (with or without previous pregnancy)
12 two or more abortions
O f the 26 first pregnancy aborters 10 were sampled at a 3 months follow up visit 
and 9 were sampled in a following pregnancy.
3.3.2 Results
Tables below show means and standard deviations (sd). Where there is 
insufficient data to calculate the sd an asterisk * has been inserted.
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3.3.2.1 Inter-cycle variation Stimulation Index
Because the data were not normally distributed, a non parametric 
statistical analysis (Mann Whitney) was carried out.
IgG IgM
mean sd mean sd
follicular n = 10 3.56 9.66 7.55 11.31
luteal n =  16 1.212 0.667 11.54 24.64
day 14 n = 14 2.229 0.812 4.42 4.99
menstruating n =  8 0.259 0.096 1.64 9.14
Table 3.5. Inter cycle Variation Immunoglobulin Stim ulation Indexes
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Figure 3.5. Box and Whisker plot; Im m unoglobulin Stimulation Indexes 
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The following table summarises the statistics carried out on the above data. Nsd 
=  no significant difference.
versus follicular luteal day 14
luteal nsd
day 14 nsd nsd
menstruating nsd nsd nsd
Table 3.6. Inter cycle Variation Statistics Immunoglobulin
Comparison o f the results obtained at the various stages o f the menstrual cycle, 
as outlined above, showed there to be no significant difference either IgG or
3.3.2.2 Non pregnant v Pregnant Stimulation Index
IgG IgM
S.L mean sd mean sd
Normal non-pregnant n =  48 1.839 4.894 7.29 16.25
Normal pregnant n = 20 0.807 2.111 5.53 7.38
0+° n = 9 (pregnancy sub group) 1.045 2.691 6.76 9.59
1+° n =  2 (pregnancy sub group) -0.20 ★ -0.13 ★
24- n =  3 (pregnancy sub group) 1.74 3.14 4.05 5.95
34- ° n = 1 (pregnancy sub group) 7.29 ★ 7.29 ★
1 + 1 n = 1 (pregnancy sub group) 0.59 ★ 10.21 ★
Pregnant no previous abortion 1.434 2.915 5.34 7.99
n =  15
Multi-parous no previous abortion. 2.02 3.4 8.69 9.64
n =  6
all pregnant n =  29 0.664 1.805 4.19 6.55
* denotes insufficient data to obtain these figures
Table 3.7. N on Pregnant v Pregnant Immunoglobulin Stim ulation
Indexes
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The following table summarises the statistics carried out on the above data.
versus normal 0+° pregnant multi-parous
non no previous no previous
pregnant abortion abortion
0+° nsd
pregnant no nsd nsd
previous abortion
multi-parous no nsd nsd nsd
previous abortion
all pregnant IgG
p = 0.0355
(pregnant lower)
nsd nsd nsd
Table 3.8. N on Pregnant v Pregnant Statistics Immunoglobulin
The results suggest a reduced capacity o f B cells to produce IgG in pregnant 
women when compared to non pregnant women.
IgG
40
35
30
25
S.l. 20
10
pregnantnon pregnant
Figure 3.6. Box and Whisker plot; IgG Immunoglobulin Stimulation Indexes, 
N on  Pregnant v Pregnant
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3.3.2.3 Non pregnant v Abortion Stimulation Index
IgG IgM
S.I. mean sd mean sd
non pregnant n =  48 1.839 4.894 7.29 16.25
1st pregnancy aborter n = 26 3.15 8.36 7.14 14.32
1st aborter (regardless parity) n =  11 2.69 3.92 20.03 42.6
all 1st aborters n =  37 3.02 7.27 10.98 25.8
all aborters n =  49 5.11 19.31 8.78 22.49
Table 3.9. N on Pregnant v Abortion Immunoglobulin Stim ulation
Indexes
The following table summarises the statistics carried out on the above data.
versus non l rt pregnancy l rt aborter all l rt
pregnant aborter regardless
parity
aborters
1st pregnancy nsd
aborter
1st aborter nsd nsd
regardless
parity
all 1st aborters nsd nsd nsd
all aborters nsd nsd nsd nsd
Table 3.10. N on Pregnant v Abortion Statistics Immunoglobulin
The results indicate no alteration o f B cell function between non pregnant 
women and those undergoing abortion. There is also no significant difference in
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B cell function between various first abortion sub groups.
3.3.2.4 Normal pregnancy v Abortion Stimulation Index
IgG IgM
S.I. mean sd Mean sd
o
pregnant 0+  n =  9 1.045 2.691 6.76 9.59
all pregnant n =  29 0.664 1.805 4.19 6.55
1st pregnancy aborter n = 26 3.15 8.36 7.14 14.32
all 1st aborters n =  37 3.02 7.27 10.98 25.8
> 1 abortion n =  12 11.6 37.3 2.57 4.37
all aborters n =  49 5.11 19.31 8.78 22.49
Table 3.11. Pregnant v Abortion Immunoglobulin Stim ulation Indexes
The following table summarises the statistics carried out on the above data.
versus 0+ ° all l rt all l rt >1
pregnant pregnancy aborter abortion
Aborters
all pregnant 
1st pregnancy 
aborter
nsd
nsd nsd
all 1st aborters nsd nsd nsd
> 1 abortion nsd nsd nsd nsd
all aborters nsd nsd nsd nsd nsd
Table 3.12. Pregnant v Abortion Statistics Immunoglobulin
The results indicate no alteration o f B cell function between normal pregnant 
women and those undergping abortion. There is also no significant difference in
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B cell function between various abortion sub groups. Recurrent aborters ie > 1 
abortion do not differ significantly from spontaneous aborters for B cell 
function.
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3.3.2.5 Abortion Stimulation Index
IgG IgM
S.I. mean sd mean sd
1st pregnancy aborter n =  26 3.15 8.36 7.14 14.32
1st aborter regardless parity n = 11 2.69 3.92 20.3 42.6
all 1st aborters n = 37 3.02 7.27 10.98 25.8
2nd aborters n = 10 13.9 40.8 2.83 4.72
3rd aborters n = 1 -0.19 ★ -0.72 ★
4th aborters n =  1 - 1.0 ★ 3.59 ★
> 1 aborter n = 12 11.6 37.3 2.57 4.37
all aborters n =  49 5.11 19.31 8.78 22.49
Table 3.13. Abortion Immunoglobulin Stim ulation Indexes
The following table summarises the statistics carried out on the above data.
versus 1st l rt abortion a lll* 2nd >1
pregnancy regardless aborters aborters abortion
aborter parity
1st abortion nsd
regardless
parity
all 1st aborters nsd nsd
2nd aborters nsd nsd nsd
>1 abortion nsd nsd nsd nsd
all aborters nsd nsd nsd nsd nsd
Table 3.14. Abortion Statistics Immunoglobulin
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Again no significant difference in B cell function is detected between these
abortion sub groups.
3.3.2.6 Results at follow up of aborters Stimulation Index
IgG IgM
S.I. mean sd mean sd
1st visit n =  26 (aborting) 3.15 8.36 7.14 14.32
3/12 follow-up n =  10 3.02 9.76 2.02 5.58
2nd pregnancy n =  9 0.344 0.811 1.082 1.928
Table 3.15. Follow Up Patients Stim ulation Indexes Immunoglobulin
The following table summarises the statistics carried out on the above data.
versus l rt pregnancy aborter 3/12 follow  up
3/12 follow up nsd
2nd pregnancy nsd nsd
Table 3.16. Follow Up Patients Statistics Immunoglobulin
Comparison was also carried out between the group o f 2nd pregnancy samples 
with the normal pregnant group. While there was no significant difference 
between these groups for IgG, IgM was found to be significantly higher 
(p = 0.0464) in normal pregnant than in the “follow up” pregnant samples.
3.3.3 Discussion
N o significant differences in production o f immunoglobulin was 
detected throughout the menstrual cycle. Levels o f IgG in vaginal fluids have
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been reported to fluctuate with the menstrual cycle (Usala 1989), being relatively 
high after menstruation, declining in the ovulatory phase and remaining low in 
the luteal phase. De Punzio et al (1992) also found this fluctuation in IgA levels 
in vaginal fluids. The variations were small and not statistically significant. 
Vaginal fluid consistency and volume alters throughout the menstrual cycle and 
this, along with fluctuating pH  levels in the vagina, may affect the levels of 
immunoglobulins present. From this present study it would appear that this local 
fluctuation is not reflected in the peripheral blood.
N o significant differences in immunoglobulin levels were detected between the 
various sub groups o f pregnancy.
Pregnant women were found to have lower S.l. for IgG than non pregnant 
women. Yasuhara et al (1992) found serum levels o f IgG, IgA and IgM decreased 
throughout pregnancy. Levels o f agalactosyl IgG were found to decrease during 
pregnancy by one group (Thompson et al 1992). The level o f agalactosyl IgG 
correlates with the severity o f arthritis. The symptoms o f arthritis are known to 
be less severe during pregnancy. This may be a case o f a temporary 
immunosupression having a beneficial effect on a disease o f immune origin. If  
the T h2 bias o f pregnancy postulated by Wegmann (1993) and discussed in the 
introduction o f this thesis is correct then B-cells taken from pregnant woman 
will be up-regulated and producing large amounts o f antibody. Stimulation o f 
these, already up regulated cells, might not result in the production o f large 
amounts o f antibody and the stimulation index would therefore be smaller as 
was found when comparing pregnant with non pregnant women.
Immunosuppression in pregnancy has been much considered over the years.
The maternal immune system must be directed to tolerate the foreign foeto-
placental unit, immunosupression would aid such tolerance. It has been noted 
that pregnant women suffer more severe symptoms from some viral infections 
such as influenza and pneumonia than non pregnant women but are not at risk 
from more frequent or more severe infections from most viral or bacterial 
pathogens (Adelsberg 1985). Adelsberg proposed that immunosuppression does 
play a role in the maintenance o f a normal human pregnancy but that it is likely 
to be quite specific, utilising specific antibodies, immune complexes or 
lymphocytes, and/or quite localised, i.e., that the development o f reactive 
maternal cells is prevented in and around the placenta but not necessarily 
elsewhere in the mother. Hegde (1991) found very little change in the immune 
competence o f the mother during pregnancy. This makes sense, as generalised 
immunosupression would be a risky way to ensure the survival o f the foetus, the 
mother being prone to infection. Declining titres o f anti-viral antibodies have 
been noted in the blood o f pregnant women (Baboonian 1983), but this is 
thought to be predominantly a manifestation o f haemodilution (ie the increased 
volume of blood in pregnant women).
Some thyroid diseases, particularly autoimmune thyroid disease, tend to be less 
severe during pregnancy and other autoimmune diseases are also known to go 
into remission. During pregnancy levels o f circulating lymphocyte subsets such 
as CD 4+ve are reduced and natural killer cell activity is depressed (Lazarus
1994). This modification o f the maternal immune response appears to have a 
significant influence on disease activity in autoimmune disorders.
N o statistical difference in B cell production o f immunoglobulins was detected 
between women undergoing abortion and non pregnant women. This was also 
the case between women undergoing abortion and pregnant women. There was
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also no difference found in the various sub groups o f  abortion. MacLean et al 
(1991) reported higher levels o f IgG and IgM in pregnant women as well as 
spontaneous aborters when compared to non pregnant women. Their data 
however, was calculated on total immunoglobulin produced by stimulated B 
cells whereas this study looks at a stimulation index. The stimulation index is a 
measure o f B cells capacity to produce immunoglobulin under stimulation and is 
an attempt to compensate for the large variation o f total immunoglobulin found 
in individuals’ controls. For instance a sample with lOng/ml IgG in the control 
and lOOng/ml in the stimulated sample would have a SI o f 9 and a sample with 
90ng/ml IgG in the control and lOOng/ml in the stimulated sample would have a 
SI o f 0.11. Both o f these examples would have the same value in total IgG 
measured. Maclean et al reported large standard deviations in their data and also 
had a lower number o f patients than this study.
Chapter Four
Reactive Oxygen Species
4.1 Reactive Oxygen Species
Reactive Oxygen Species (ROS) are also sometimes known as free radicals, 
a term that is not strictly correct as not all biologically important oxidants are 
radicals (e.g. hydrogen peroxidase). Radical reactions are an integral part o f 
homoeostasis in cellular processes. Many cellular enzymes catalyse reactions by 
utilising one-electron transfers that produce reactive intermediate oxygen species. 
This is also the case for energy producing electron transport systems. Molecular 
oxygen, found in all aerobic organisms, readily accepts electrons. This results in the 
formation o f ROS. The production o f ROS must be tightly controlled as they can 
be highly destructive to cells. The body has a complicated anti-oxidant system with 
enzymatic and non enzymatic components to keep in check levels o f ROS. Thus 
the body receives the benefits o f ROS biochemistry without the risk o f uncontrolled 
reactions harming its physiology. ROS can cause damage to tissue when the balance 
between their production and levels o f anti-oxidant protective mechanisms tips in 
favour o f ROS production.
4.1.1 Reactive Oxygen Species and Disease
Damage caused by the formation o f ROS has been implicated in a number 
o f pathologic conditions. Mutagenesis through oxidative DNA damage is widely 
hypothesised to be a frequent event in the normal human cell. ROS-related lesions 
that do not cause cell death can stimulate the development o f cancer (Dreher 1996). 
It is believed that ROS play a critical role in the development o f cardiovascular 
disease (Barber 1994), the autoimmune disease rheumatoid arthritis (Banford 1982) 
and in thyrotoxicosis (Wilson 1988). ROS damage has been implicated in the
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atherogenic process, whereby there is degeneration o f the arteries due to the 
formation in them of fatty plaques and scar tissue (Tse 1994). Oxidative injury may 
be increased in diabetes mellitus because o f a weakened defence to reduced 
endogenous antioxidants such as vitamin E and reduced glutathione (Giugliano
1995). Hypertension (high blood pressure) is a pathological state that may be 
associated with a loss o f the balance between pro-oxidation and antioxidation 
(RomeroAlvira 1996). Pregnancy induced hypertension (PIH) develops in the latter 
stages (usually after week 20) o f pregnancy and resolves at about 6 weeks post 
partum. Changes in the antioxidant systems in late pregnancy and in PIH have been 
noted (Wisdom 1991, Pandey 1995). In normal pregnancy lipid peroxides increase, 
but antioxidants also increase to offset their toxic actions (Walsh 1994). However, 
this is not the case in pre-eclampsia. In women with pre-eclampsia, circulating 
levels o f lipid peroxides are increased, but net antioxidant activity is decreased as 
compared to normally pregnant women.
Extracellular and intracellular antioxidant buffering levels were found to be 
decreased in patients with PIH, especially in those with proteinuria, compared to 
levels found in normal pregnancy (Chen 1994).
4.2 Subject Population
In this study two intracellular anti-oxidants, lysate thiol (LSH) and 
superoxide dismutase (SOD), as well as two extracellular anti-oxidants, plasma thiol 
(PSH) and caeruloplasmin (Cp) were measured. The methods are described in 
chapter 2.
The assay for measurement o f the thiol groups was based on the thiol-disulphide
106
interchange reaction between 5,5’-dithio-bis’-nitrobenzoic acid and biological 
thiols. Caeruloplasmin activity in plasma was assessed on the basis o f the 
caeruloplasmin catalysed oxidation o f p-phenylenediamine to Bandrowski’s base. 
The increased rate o f photo-oxidation o f o-dianisidine was the basis o f superoxide 
dismutase measurement. When looked at together, these four parameters are a 
measure o f the redox status o f the cell and the oxidative stress across the cell 
membrane , as reflected by two intra and two extra cellular parameters.
In vitro studies o f cultured luteal cells (cells from the corpus luteum) have provided 
evidence which suggests that ROS play an important role in luteolysis (degeneration 
o f the corpus luteum) in the rodent ovary (Rueda 1995). Recent findings have 
indicated that luteal cells employ ROS at specific sites in controlling the production 
o f progesterone over the course o f the menstrual/reproductive cycle, and inhibiting 
its synthesis during regression (Carlson 1993). Levels o f anti oxidants in the 
peripheral blood may therefor differ according to the stage in the menstrual cycle. 
To see if  this is so, samples were taken from women with a normal menstrual cycle 
at various stages and anti oxidant levels were measured. Levels o f anti oxidants for 
these women were also compared to those found in normal males.
Free radical toxicity in pregnancy and abortion (induced and spontaneous) has 
previously been noted (Sane 1991). Blood samples from normal pregnant women 
and women suffering spontaneous abortion were collected for measurement o f 
antioxidant levels.
The following groups were included in the study:
Non pregnant females (Group 1). Sixty samples were obtained from women, not on the 
oral contraceptive pill, with a mean menstrual cycle o f 28 plus or minus 3 days
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duration. The women were aged 29.4 ± 4.5 years. The samples were obtained from 
43 women at the following stages o f their menstrual cycle;
12 follicular phase (day 5-9)
18 luteal phase (day 18-22)
18 ovulating (day 14)
12 menstruating
Normal Males (Group 2). Anti-oxidant levels were measured in samples from 19 
healthy male volunteers. They were not taking any medication and were aged 30.5 ± 
6.3 years
Pregnant (Group 3). A total o f 28 samples from women in the first trimester o f 
pregnancy were assayed. The women were aged 27.2 ± 5.5 years. O f  these 10 were 
from primigravida women, 7 were from women with a history o f successful 
pregnancy outcome and 2 women had suffered a miscarriage previous to this study 
(one o f these also had a previous successful pregnancy). The remaining 9 samples 
were from women who had been seen at the start o f this study when admitted to 
hospital suffering a spontaneous abortion, but these samples taken in a following 
pregnancy. For statistical analysis this group o f 9 women were also treated as a sub 
group.
Aborters (Group 4). A total o f 60 samples were taken from women admitted to 
hospital suffering a spontaneous abortion. Blood was taken from these women prior 
to them gping to theatre. They were grouped as follows;
22 first pregnancy aborters (primary aborters)
19 first time aborters with previous successful pregnancy (secondary
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aborters)
16 women aborting for the second time 
2 women aborting for the third time 
1 woman aborting for the fourth time.
For the purpose o f statistics, analysis was carried out on the following groups;
60 all aborters (age 27.5 ± 5.8 years)
41 first aborters (with or without previous pregnancy) (age 25.5 ± 4.8 years) 
19 two or more abortions (age 29.1 ±6.1 years)
O f the 22 first pregnancy aborters 13 were re-sampled at a 3 months follow up visit 
and 9 were re-sampled in a following pregnancy.
4.3 Results
Tables below show means and standard deviations (sd). Where there is 
insufficient data to calculate the sd an asterisk (*) has been inserted.
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4.3.1 Normals (Male v Female)
PSH LSH C p SO D
(U/ml) (U/ml) (mg/dl) (pg/ml)
mean sd mean sd mean sd mean sd
female 427.75 62.87 407.80 149.2 18.02 5.55 42.52 23.00
male (n=19) 516.80 32.70 397.4 96.5 15.52 2.05 43.51 13.87
Table 4.1. Female v Male Free Radicals
Because the data was not normally distributed, a non parametric statistical analysis 
(Mann Whitney) was carried out.
The results o f the group o f all non pregnant females was compared with the group 
o f males. N o significant difference occurred between the groups for LSH, Cp or 
SOD. For PSH, male levels were significantly increased when compared to female 
(P=0.0001).
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Figure 4.1. B o x  a n d  W h isk e r p lo t; P S H  fe m a le  v  m a le .
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4.3.2 Inter-cycle variation
PSH LSH C p SO D
(U/ml) (U/ml) (mg/dl) (pg/ml)
mean sd mean sd mean sd mean sd
follicular 414.8 65.2 492.9 164.8 17.5 7.35 31.08 13.39
luteal 440.3 64.3 364.3 130.0 17.78 6.31 48.59 31.87
day 14 428.5 52.7 379.9 162.0 18.66 3.87 44.07 20.53
menstruating 420.8 75.9 427.5 115.6 17.98 4.82 41.55 14.46
Table 4.2. In te r cycle V ariation  Free Radicals
Comparison o f the results obtained at the various stages o f the menstrual cycle, as 
outlined above, showed there to be no significant difference in any o f the 
parameters measured, apart from LSH, where samples measured in the follicular 
phase were found to be significantly higher than those in the luteal phase 
(P = 0.0466).
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Figure 4.2. B ox an d  W hisker p lo t; L S H  M en stru a l Cycle.
I l l
4.3.3 Non pregnant v Pregnant
PSH LSH C p SO D
(U/ml) (U/ml) (mg'dl) (pg/ml)
mean sd mean sd mean sd mean sd
N on pregnant 427.75 62.87 407.8 149.2 18.02 5.55 42.52 23.0
0+ ° 445.1 78.3 385.9 251.2 21.95 3.86 53.93 21.38
1 + ° 386.3 88.7 342.0 227.0 25.67 8.58 54.8 42.2
2 + ° 406.0 ★ 373.0 196.0 27.33 6.66 25.93 10.55
3 + ° 295.0 211 166.0 ★ 30.5 ★ 74.0 ★
0 + 1 413.0 ★ 478.0 ★ 33.0 ★ 64.0 ★
1 + 1 415.0 ★ 234.0 ★ 33.0 ★ 66.0 ★
Pregnant 412.8 102.1 363.0 222.8 24.06 5.57 50.32 25.53
Multi-parous 359.0 121.0 330.3 188.6 27.07 6.5 45.2 31.6
all pregnant 443.7 93.1 356.5 177.2 23.96 5.71 51.92 21.91
* denotes insufficient data to obtain these figures
Table 4.3. N o n  P reg n an t v  P reg n an t Free R adicals
Results from non pregnant women were compared to those from pregnant women. 
No significant difference was detected in the measurements o f the plasma or lysate 
thiols between results from non pregnant women and any o f the pregnancy sub 
groups.
For Cp the result o f the non pregnant samples was found to be significantly lower
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than the pregnant samples (P=0.0001). N on pregnant samples were significantly 
lower than the primigavidae samples (P=0.0198), the multigravidae samples (P= 
0.0017) and the samples from pregnant women with no history o f abortion (P= 
0.0003).
Cp
35
30
25
o>
20
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pregnant previous abortion
Figure 4.3. Box and  W hisker plot; C p N on  P reg n an t v  P regnan t.
Levels o f SOD were significantly raised in the group o f all pregnant women 
compared to non pregnant (P=0.0219) and also in the group not including the 9 
follow up samples (P =0.0187). There was no significant difference in SOD value 
between non pregnant and any o f the pregnancy sub groups (i.e. prim, multi, no 
history o f abortion).
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Figure 4.4. B o x  and W hisker p lot; S O D  N o n  P reg n a n t v  P regnan t.
4.3.4 Non pregnant v Abortion
P SH
(U/ml)
LSH
(U/ml)
C p
(mg/dl)
SO D
(pg/ml)
mean sd mean sd mean sd mean sd
non pregnant 427.75 62.87 407.8 149.2 18.02 5.55 42.52 23.0
1st pregnancy 
aborter
406.5 68.3 422.4 150.4 19.9 6.15 38.75 20.43
1st aborter 
(regardless 
parity)
417.1 75.8 391.4 166.7 22.07 9.4 33.28 15.61
all 1st aborters 411.4 71.1 408.0 156.9 20.87 7.75 36.29 18.4
all aborters 406.7 85.8 398.6 170.5 21.13 7.06 38.52 17.85
Table 4.4. N on  P reg n an t v  A bortion  Free Radicals
Results from normal, non pregnant, women were compared to those from aborting 
women. N o significant difference was detected in the measurements o f the plasma
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or lysate thiols or for levels o f SOD.
For Cp the result o f all abortion samples (group 3) was found to be significantly 
higher than the non pregnant (group 1) samples (P=0.0048). While no significant 
difference between non pregnant samples and first pregnancy abortion occurred 
non pregnant samples were found to be significantly lower than secondary aborters 
(P= 0.0129). N on pregnants were significantly lower than the group o f first time 
aborters (with or without a previous successful pregnancy) (P = 0.021).
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Figure 4.5. Box and Whisker plot; Cp Non Pregnant v Abortion.
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4.3.5 Pregnancy v Abortion
PSH
(U/ml)
LSH
(U/ml)
C p
(mg/dl)
SO D
(pg/ml)
mean sd mean sd mean sd mean sd
- 0
pregnant 0+ 445.1 78.3 385.9 251.2 21.95 3.86 53.93 21.38
all pregnant 443.7 93.1 356.5 177.2 23.96 5.71 51.92 21.91
1st pregnancy 
aborter
406.5 68.3 422.4 150.4 19.9 6.15 38.75 20.43
all 1st aborters 411.4 71.1 408.0 156.9 20.87 7.75 36.29 18.4
> 1 abortion 279.0 112.9 378.1 199.8 21.68 5.48 43.46 15.93
all aborters 406.7 85.8 398.6 170.5 21.13 7.06 38.52 17.85
Table 4.5. Pregnant v Abortion Free Radicals
Normal primigravid women were compared with women aborting in their first 
pregnancy. There were no significant differences for PSH, LSH or Cp, but for SOD 
results for these pregnant women were significantly higher than this group of 
aborting women (P = 0.0463).
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Figure 4.6. Box and Whisker plot; SOD 0+ 0 v 1st Pregnancy Aborters.
Normal primigravid women were compared with women aborting for the first 
time, though not necessarily in a first pregnancy. There were no significant 
differences for PSH, LSH or Cp, but for SOD results for these pregnant women 
were significantly higher than this group o f aborting women (P = 0.0129).
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Figure 4.7 Box and Whisker plot; SOD 0+° v All 1*  Aborters
Normal primigravid women were compared with women who had suffered more 
than one abortion. There were no significant differences for PSH, LSH, Cp or 
SOD results.
Normal primigravid women were compared with the group o f all aborters. Again 
there were no significant differences for PSH, LSH or Cp, but SOD results for 
these pregnant women were significantly higher than this group o f aborting women 
(P = 0.0339).
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Figure 4.8. Box and Whisker plot; SOD 0+ 0 v All > lst Aborters.
The group of all pregnant samples was compared to first pregnancy aborters, No 
significant difference was detected for PSH or LSH.
Cp levels were significantly higher in the group o f all pregnant women than in the 
group o f first pregnancy aborters (p = 0.0323).
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Figure 4.9. Box and Whisker plot; Cp Pregnant v 1st Pregnancy Aborters
SOD levels were significantly higher in the group o f all pregnant women than in the 
group o f first pregnancy aborters (p=0.0218).
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Figure 4.10. Box and Whisker plot; SOD Pregnant v*lPregnancy Aborters
120
4.3.6 Abortion
PSH LSH Cp SO D
(U/ml) (U/ml) (mg/dl) (Hg/ml)
mean sd mean sd mean sd mean sd
1st pregnancy 406.5 68.3 422.4 150.4 19.9 6.15 38.75 20.43
aborter
1st aborter 417.1 75.8 391.4 166.7 22.07 9.4 33.28 15.61
regardless parity
all 1st aborters 411.4 71.1 408.0 156.9 20.87 7.75 36.29 18.4
2nd aborters 402.3 108.5 391.6 214.0 21.62 5.92 43.69 15.86
3rd aborters 330.0 206.0 344.5 68.6 21.0 2.83 44.5 27.6
4th aborters 436.0 ★ 230.0 ★ 24.0 ★ 38.0 ★
> 1 aborter 279.0 112.9 378.1 199.8 21.68 5.48 43.46 15.93
all aborters 406.7 85.8 398.6 170.5 21.13 7.06 38.52 17.85
* denotes insufficient data to obtain these figures
Table 4.6. Abortion Free Radicals
N o significant difference was found when comparing all the different abortion 
groups for any o f the parameters measured.
4.3.7 Spontaneous aborters followed up
O f the 22 primigravida patients admitted with a spontaneous abortion, 13 
were seen 3 months after their abortion . O f  these 13 patients, 9 were seen in a later 
pregnancy. Comparing this group o f patients at these times gave the following 
results (table 4.7).
PSH LSH Cp SOD
(U/ml) (U/ml) (mg/dl) (pg/ml)
mean sd mean sd mean sd mean sd
1st visit 406.5 68.3 422.4 150.4 19.9 6.15 38.75 20.43
3/12 follow-up 425.2 95.5 363.5 194.6 19.38 3.17 34.74 11.57
2nd pregnancy 497.0 88.1 274.7 123.4 24.06 6.22 46.88 21.17
Table 4.7. Follow Up Patients Free Radicals
There was no significant difference in these women at first admission compared to 
3 months later for any o f the parameters measured. For Cp and SOD there was no 
significant difference between results obtained on first admission compared to a 
following pregnancy. PSH levels for the following pregnancy were significantly 
higher than those at first admission (P = 0.0049), while LSH levels were significantly 
lower in the following pregnancy than in the initial sample (P=0.0148). Analysis 
was made o f the results from the 9 pregnant women with those o f the normal 
pregnant group. There was no significant difference for any o f the parameters 
measured.
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The following table gives a 
summary o f significant 
differences found between 
the various groups.
P S H LSH C p SO D
non pregnant female v 
male
p =  0.0207 
(malesT)
nsd nsd nsd
menstrual cycle 
follicular v luteal
nsd p =  0.0466 
(follicular t )
nsd nsd
non pregnant v pregnant nsd nsd p =  0.0001
(pregT)
p =  0.0187 
(p reg t)
non pregnant v aborters nsd nsd p =  0.0048 
(aborters T)
nsd
0+ v ly aborters nsd nsd nsd p =  0.0463 
(prims t )
0+° v 1st aborters nsd nsd nsd p =  0.0129 
(prims t )
o0+ v all aborters nsd nsd nsd p =  0.0339 
(prims t )
pregnant v ly  aborters nsd nsd p=  0.0323 
(aborters >1)
p =  0.0218 
(aborters >1)
all pregnant v all aborters p=  0.0310 
(abortersi)
nsd nsd p =  0.0023 
(aborters -1)
0+° = women in first pregnancy; ly aborters = women aborting first pregnancy; 1st 
aborters =  ly  aborters +  women aborting for first time following successful 
pregnancy
Table 4.8. Free Radicals Summary o f Results
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4.4 Discussion
I have been unable to find any previous mention in the literature o f  how 
gender affects free radical scavenger levels in the blood. The conclusion o f this 
study is that in all but one parameter measured there is no significant difference. 
PSH levels were found to be significantly lower in females than in males. This 
difference was only detected between males and the large group o f all non pregnant 
females, ie there was no significant difference in PSH levels between males and any 
o f the small menstrual cycle sub groups o f non pregnant women. The implications 
o f this difference in PSH is unclear, as with lower levels o f extra-cellular thiol you 
might expect to find raised levels o f intracellular thiol, but it must be stressed that 
future studies must take care to sex match control and study groups.
Scavenger levels were compared throughout the menstrual cycle. LSH levels were 
found to be significantly lower in the luteal phase when compared to the follicular 
phase. Oxidative stress will result in the conversion o f thiol groups to disulphide 
forms with a consequent fall in the observed thiol level. There is evidence 
supporting a role for oxidative stress in luteolysis (the regression o f the corpus 
luteum which occurs after ovulation and where no fertilisation and nidation has 
taken place) (Rueda 1995). Rueda noted that levels o f SOD, catalase and glutathione 
peroxidase increase at the time of luteal cell demise in the bovine ovary. The 
observed drop in LSH level may be a reflection, in the peripheral blood, o f this local 
increase in oxidative stress.
Levels o f SOD and Cp were significantly higher in pregnant women when 
compared to non pregnant controls. All the pregnant women were in the first 
trimester o f pregnancy. A previous study (Wisdom 1991) found higher levels o f Cp
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in women in later (third trimester) pregnancy when compared to non pregnant 
controls. This present study indicates that Cp levels rise at an early stage in 
pregnancy. This concurs with an early study (Cranfieldl979) where it was found 
that serum antioxidant activity progressively increased throughout pregnancy. 
Wisdom found SOD levels to be lower in pregnancy than in non pregnant controls. 
However, the mean SOD level quoted for non pregnants in his study is very high 
(62 pg^ml) compared to that found in this study (42.52 pg/ml).
It is also important to note that as stated in the methods chapter 2 the intra assay 
variation for the SOD assay is very high (39.5%) and therefore results o f this assay 
must be interpreted with caution.
As mentioned in the introduction to this chapter antioxidants rise in pregnancy to 
offset toxic actions o f lipid peroxides. This is not the case in women with pre­
eclampsia in the third trimester, ie abnormal pregnancy (Walsh 1994). In this study 
some anti-oxidants were decreased in pregnancies failing in the first trimester.
Cp levels were significantly higher in the group o f all aborters compared to non 
pregnant women. Sane (1992) noted elevated levels o f serum lipid peroxide, i.e. 
evidence of increased free radical activity, in women undergoing abortion (induced 
or spontaneous). He attributed this rise to the high degree o f stress these women 
were undergoing and found that the levels dropped at the end o f the stress. Samples 
for this present study were taken from women admitted during or immediately 
following a spontaneous abortion. It might be concluded that samples taken earlier 
(i.e. all samples taken during abortion) might have revealed raised levels in the other 
parameters, and not just Cp. It might be interesting to compare free radical levels in 
abortion with other stressful situations, such as surgery for other reasons. It is
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interesting to note that women seen three months after their abortion (stress) did 
not have significantly different levels o f antioxidants compared to non pregnant 
women.
In all the comparisons made between the various groups o f aborters and pregnant 
women, when significant differences were found, levels were found to be higher in 
pregnancy. Perhaps if  pregnancy is to have a successful outcome free radical 
scavenger levels have to increase.
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Chapter Five
Cytokines
5.1 Cytokines
Cytokines are a group o f hormone-like polypeptide mediators that play a 
variety o f regulatory roles in both host defence and normal and abnormal 
homeostatic mechanisms (Cohen 1996). As well as being potent mediators o f 
inflammatory and immune responses they mediate a variety o f non immunologic 
phenomena. A search o f the scientific literature between 1990 and 1996 for the 
word “cytokine” found 25,063 documents, a reflection o f the importance given to 
these substances. Sub groups of cytokines are variously known as lymphokines, 
monokines, interleukins, interferons and certain growth factors. These groups have 
the following characteristics in common:
They are low molecular weight proteins (<  80kDa).
They are involved in regulating the size and duration o f response in immunity and 
inflammation.
They are usually locally produced and act in a paracrine, juxtacrine or autocrine 
manner (Provided that the appropriate receptors are expressed on the cell surface, 
cytokines can act on the cells that secrete them [autocrine growth control], 
immediately adjacent cells [juxtacrine growth control], or neighbouring cells 
[paracrine growth control]).
They are very potent, acting in picomolar concentrations.
They interact with high affinity cell surface receptors specific for each cytokine or 
cytokine group.
Binding o f a cytokine to a cell surface leads to altered protein synthesis and to
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altered cell behaviour.
They have overlapping regulatory actions.
They interact in a network, by inducing each other; by transmodulating cytokine 
cell surface receptors and by synergistic, additive or antagonistic interactions on cell 
function.
(Balkwill et al 1989).
Most cytokines have growth factor activity, while only some, such as the interferons 
and tum our necrosis factor (TNF), act to inhibit cell growth. The majority o f 
cytokines act on T  cells and B cells, with a combination o f cytokines often required 
to obtain a response. Cytokine regulation o f major histocompatibilty complex 
(MHC) expression and action on macrophages, granulocytes, natural killer cells and 
eosinophils appears to be more restricted.
5.2 Interleukins
Interleukins are a series of lymphocytotrophic hormones. They are a group 
of hormone-like polypeptide mediators that play a variety o f regulatory roles in both 
host defence and normal and abnormal homeostatic mechanisms in much the same 
way as hormones and their receptors act on the endocrine system. Eighteen 
different interleukins have been identified to date, though the list is sure to expand.
Tables 5.1a and 5.1b summarise the interleukin family to date, their previous names 
and some indication o f their functions.
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Interleukin Previous Names or Function
IL-1 Lymphocyte Activating Factor 
Endogenous Pyrogen (EP)
Mitogenic Protein (MP)
Helper Peak-1 (HP-1)
T  Cell Replacing Factor III (TRF III) 
B Cell Activating Factor (BAF)
B Cell Differentiating Factor (BDF)
IL-2 T  Cell Growth Factor (TCGF)
T  Cell Maturation/Stimulation Factor 
Killer Helper Factor (KHF)
T  cell replacing Factor (TRF)
IL-3 Colony Forming Unit-stimulating activity 
(CFU-SA)
Multiple Colony Stimulating Factor (Multi- CSF)
IL-4 B Cell Stimulatory Factor-1 (BSF-1)
T  Cell Growth Factor-2 (TCGF-2) 
Mast Cell Growth Factor-2 (MCGF-2)
IL5 Eosinophil Differentiating Factor (EDF)
B Cell Growth Factor-H (BCGF-II)
T  Cell Replacing Factor (TRF)
IgA Enhancing Factor (IgA-EF)
Eosinophil colony stimulating Factor (EOCSF)
Table 5.1a Interleukins
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Interleukin Previous Names or Function
IL-6 Plasmacytoma Growth Factor (PCT-GF)
Interferon-b-2 (IFN-b2)
Monocyte derived human B cell growth factor
B Cell Stimulating Factor (BSF-2)
Hepatocyte Stimulating Factor (HSF)
Interleukin Hybridoma/Plasmacytoma-1
(IL- HP1)
IL-7 B Cell Growth Factor
IL-8 Monocyte derived neutrophil chemotactic factor
Neutrophil-Activating Peptide-1 (NAP1)
IL-9 Mast cell growth factor P40
IL-10 TH1 Cytokine Synthesis Inhibitor
IL-11 Adipogenesis Inhibitory Factor (AGIF)
IL-12 Natural Killer Cell Stimulatory Factor (NKSF)
T  cell stimulating factor
IL-13 Induces B cell proliferation
IL-14 High molecular weight B cell growth factor (HMW-BCGF)
IL-15 Stimulates the proliferation o f T  lymphocytes. Produced by a
wide variety o f cells and tissues, it shares many biological
properties with 11-2
IL-16 Lymphocyte chemoattractant factor (LCF) All o f its biological
activities depend upon the cell surface expression o f CD4.
IL-17 Cytotoxic T-cell lymphocyte-associated antigen-8 (CTLA-8)
IL-18 Interferon-gamma-inducing Factor (IGIF)
Table 5.1b Interleukins
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The following cytokines were measured in this study:
5.2.1 Interleukin 1 (IL-1)
Originally known as Lymphocyte Activating Factor, IL-1 activates T  cell 
lymphocytes which then proliferate and secrete Interleukin 2 (IL-2) (Gery 1972). 
IL-1 is produced by many cell types such as fibroblasts, endothelial cells, 
keratinocytes and smooth muscle, but is primarily released from stimulated 
macrophages and monocytes and plays a key role in inflammatory and immune 
responses. IL-1 has been implicated as a local regulator in embryo implantation 
(Simon 1995). IL-1 has recently been discovered to be raised in follicular fluid taken 
from patients with premature luteinization (Chen, Chen et al 1995). Luteinization 
is the forming o f the corpus luteum. Premature luteinization correlates with poor 
pregnancy outcome in in vitro fertilisation (IVF). IL-1 refers to two polypeptide 
hormones, interleukin-la and interleukin-1(3. Although the two forms o f IL-1 are 
distinct gene products, they recognise the same receptor and share biological 
properties and for this study an ELISA kit that measured IL-1 [3 was used.
5.2.2 lnterleukin-2 Receptor (IL-2R)
IL-2 is an immunomodulatory factor produced by certain subsets o f T  
lymphocytes, ie CD4+ve, (Smith 1988). IL-2 has been shown to promote longterm  
growth o f activated T  cells, activation and proliferation o f natural killer (NK) cells, 
induction of gamma-interferon and B cell growth factor secretion.
Proliferation o f T  cells is initiated by the following process. Firstly the interaction of 
antigen/MHC molecule and T  cell receptor complex triggers the expression o f a
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gene, located on chromosome 4, that is responsible for IL2 production. IL2 then 
interacts with its homologous receptor IL2R. IL2 plays a critical role in antigen- 
specific immune response and the IL2/IL2R interaction determines the size and 
duration o f response.
IL-2R mediates the action o f IL-2. Although not normally detected on resting T  and 
B cells IL-2R is found on the surface of cells stimulated by an immune challenge. 
When cells are stimulated by such an immune challenge and begin to divide, the 
expression o f I1-2R changes in two ways: more molecules o f I1-2R are expressed on 
the cell’s plasma membrane and a form o f the IL-2R protein is released by the 
activated cells into the fluid surrounding them (Nelson 1986). IL-2R has been 
found to be elevated in certain conditions such as ovarian cancer (Hurteau 1995), 
rheumatoid arthritis (Rubin 1990) and post renal transplant rejection (Colvin 1987). 
Raised IL-2R levels have also been found in patients with viral infections, such as 
AIDS and in certain autoimmune diseases including autoimmune thyroid disease 
(Nakanishi 1991), rheumatoid arthritis (Manoussakis 1989), systemic lupus 
erythematosus (Manoussakis 1989) and autoimmune chronic active hepatitis 
(Simpson 1995). Autoimmunity has recently been implicated as an important factor 
in miscarriage (Scott et al 1987) and so, for this present study, serum samples from 
aborters were assayed for IL-2R and compared to samples from normal pregnant 
and non pregnant subjects.
5.2.3 Interleukin 6 (IL-6)
IL-6 is a multifunctional 26 kD polypeptide that appears to be directly 
involved in the responses that occur after infection, inflammatory stimuli or injury. 
It acts on a variety o f cells, including fibroblasts, activated T  cells, B cells and
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hepatocytes. IL-6 appears to interact with IL-2 in the proliferation o f T  lymphocytes 
(Nordan 1986). IL-6 levels have been found to be raised in amniotic fluids of 
women who aborted within 30 days after the procedure to remove the fluid, when 
compared to matched controls who delivered healthy babies at term (Wenstrom 
1996).Wenstrom concluded that up to 12% o f pregnancy losses may result from 
preexisting subclinical intrauterine inflammation. They found that although the 
overall correlation between maternal serum and amniotic fluid IL-6 levels was good, 
only one of the eight cases who aborted would have been identified by a maternal 
serum IL-6 level.
5.2.4 Interleukin 8 (IL-8)
IL-8 is an 8kD protein which exhibits chemotactic activity in vitro for T  cells (Larsen 
1988), basophils and enzymes. IL-8 was originally isolated from human monocytes 
and distinguished from IL-1 by its chemotactic activity (Yoshimura 1987) It is a pro- 
inflammatory chemokine which has also been known as neutrophil chemotactic 
factor (NCF), neutrophil activating protein (NAP-1), monocyte derived neutrophil 
chemotactic factor (M DNCF) or T-lymphocyte chemotactic factor (TCF). 11-8 is 
produced by monocytes, fibroblasts and keratinocytes in response to stimulation by 
lipopolysaccharides, II-1 or T N F-a, or, in the case o f T  lymphocytes, by PHA 
stimulation. 11-8 has been shown to be present in the endometrium in normal 
pregnancy (Jones 1997). 11-1 is known to invoke 11-8 activity (Puren 1997). As levels 
o f II-1 were decreased in the serum o f aborting women in this study, we decided to 
look at serum levels o f 11-8.
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5.3 M easurement of interleukins/cytokines
The cytokines are measured in "sandwich ELISA" assays. Detailed methods 
are given in chapter two. The principle o f this type o f assay is summarised below 
and in figure 5.1.
The cytokine to be measured is the antigen in this assay. Antibody to the cytokine is 
bound onto the wells o f a microtitre plate. A set o f standards o f known 
concentration o f antigen and test solutions o f unknown concentration are added and 
allowed to bind, forming antibody/antigen complexes on the plate. The plate is now 
washed, removing any unbound antigen. A second population o f cytokine specific 
antibody conjugated to an enzyme (eg peroxidase, alkaline phosphatase) is added. 
After incubation, unbound labelled second antibody is removed by washing. 
Immobilised enzyme is detected following the addition o f a sensitive enzyme 
substrate and a coloured end product proportional to the amount o f  cytokine 
present in the standard or sample is measured.
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Sandwich ELISA assay
XXX
•  •
•  • •  •
wash
H I
T Precoated cytokine antibody Enzyme substrate
•  Cytokine present in sample
2nd antibody conjugated to enzyme
Figure 5.1 Sandw ich ELISA
5.4 Subject Population 
In te rleu k in -1
II-1 estimation by ELISA was carried out on serum samples from the 
following groups;
18 non pregnant women not on the oral contraceptive pill, with a mean 
menstrual cycle o f 28 plus or minus 3 days duration
18 women in the first trimester o f pregnancy and with no history of 
miscarriage
21 women admitted to hospital suffering a spontaneous abortion.
17 women with a history o f  recurrent miscarriage ie two or more abortions
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(rec aborter).
There was no significant age difference between the groups.
The following table summarises the results.
n - i p
(pgfaii)
mean sd
non pregnant n =  18 202.4 157.2
pregnant n=18 218.8 153.6
sp aborters n =21 51.8 49.6
rec aborter n = 17 242.4 137.0
Table 5.2 11-1 ^ re su lts
Because the data were not normally distributed, a non parametric statistical analysis 
(Mann Whitney) was carried out.
There was no significant difference in the results o f samples from non pregnant 
women compared to those o f normal pregnant women or recurrent aborters.
Results o f spontaneous aborters were found to be significantly lower than those o f 
non pregnant (p = 0.0001), pregnant (p= 0.0001) and recurrent aborters (p < 0.0001).
The following box and whiskers plot shows minimum, maximum, inter-quartile 
and median values for each group.
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Figure 5.2. Box and  w hisker p lo t; IL-1
11-6 estimation by ELISA was carried out on serum samples from the following 
groups;
12 non pregnant women not on the oral contraceptive pill, with a mean 
menstrual cycle o f twenty-eight plus or minus 3 days duration (non 
Preg)
14 women in the first trimester o f pregnancy and with no history of
miscarriage (preg)
8 women in the first trimester o f their second pregnancy and whose first 
pregnancy had spontaneously aborted (f.u. preg).
18 women admitted to hospital suffering a spontaneous abortion (spont ab).
15 women with a history o f recurrent miscarriage ie two or more abortions
(rec ab).
10 women undergoing elective termination o f pregnancy (stop).
There was no significant age difference between the three groups. Table 5.3 
summarises the results.
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11-6
(P8/ml)
mean sd
non pregnant n =  12 1.182 0.53
pregnant n =  14 36.9 133.3
f.u. pregnancy n =8 3.53 6.04
sp aborters n =  18 4.64 8.56
rec aborter n = 15 3.03 4.87
stop n =10 53.4 157.1
Table 5.3. 11-6 Results
Because the data were not normally distributed, a non parametric statistical analysis 
(Mann Whitney) was carried out.
11-6 levels were found to be significantly lower in non pregnant women when 
compared to women in 2nd pregnancy following spontaneous abortion (p = 0.0166), 
spontaneous aborters (p=0.001), recurrent aborters (p=0.0097) and women 
undergoing elective termination (p = 0.003). Mean 11-6 levels for pregnant group 
were high because one patient had level 500pg/ml. This same patient also had 
high levels o f II-1 (360 pg/ml) and 11-8 (>6000p^ml). Although there was no 
reason to exclude this patient from the group o f normal pregnant women it is 
interesting to note that removal o f her results from the statistical analysis led to 
there being a statistical difference between the group o f normal pregnant women 
and spontaneous aborters, aborters being higher (p = 0.023).
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The following box and whiskers plot shows minimum, maximum, inter-quartile 
and median values for each group.
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Figure 5.3. Box and whisker plot; IL-6
11-8 estimation by ELISA was carried out on serum samples from the following 
groups;
21 non pregnant women not on the oral contraceptive pill, with a mean 
menstrual cycle o f  28 plus or minus 3 days duration
20 women in the first trimester o f pregnancy and with no history of 
miscarriage
20 women admitted to hospital suffering a spontaneous abortion.
15 women with a history o f  recurrent miscarriage ie two or more abortions 
There was no significant age difference between the four groups. Table 5.4
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summarises the results.
11-8
(pg/ml)
mean sd
non pregnant n =21 0.333 1.528
pregnant n =20 600 1847
sp aborters n = 19 48.1 152.9
rec aborter n =  15 82.9 105.5
Table 5.4. 11-8 Results
O f the 21 non pregnant women 20 had undetectable levels o f 11-8 and one sample 
had a level o f 7pg/ml.
O f  the 20 normal pregnant women 18 had undetectable levels o f 11-8 and two 
samples each had grossly elevated 11-8 levels o f >6000pg/ml. One o f these patients 
also had high levels o f II-ip  (360 pg/ml) and 11-6 (>500 pg/ml). These results were 
not available for the other patient.
O f  the 20 women admitted to hospital suffering a spontaneous abortion 17 had 
undetectable levels o f 11-8 and the 3 others had 11-8 levels o f 104,153 and 656 pg/ml 
respectively.
O f the 15 women with a history o f recurrent abortion six (40%) had raised IL -8 
levels o f 185,202,202,206,212 and 236 pg/ml.
Because the data were not normally distributed, a non parametric statistical analysis 
(Mann Whitney) was carried out.
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There was no significant difference in the results o f samples from non pregnant 
women compared to those o f normal pregnant women or spontaneous aborters. 
There was also no significant difference in the results o f samples from normal 
pregnant women compared to spontaneous aborters.
Mann Whitney analysis o f IL-8 for non pregnants versus recurrent aborters showed 
a significant difference (p = 0.0071). Chi squared analysis o f the incidence o f 11-8 
being detected in serum o f pregnant women compared to those women who were 
recurrent aborters showed the presence o f 11-8 to be more prevalent in recurrent 
aborters (p<0.05).
I1-2R estimation by ELISA was carried out on serum samples from the following 
groups;
12 non pregnant women not on the oral contraceptive pill, with a mean
menstrual cycle o f  28 plus or minus 3 days duration
13 women in the first trimester o f pregnancy and with no history of
miscarriage
21 women admitted to hospital suffering a spontaneous abortion.
There was no significant age difference between the three groups. Table 5.5 
summarises the results.
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I1-2R
(P^ml)
mean sd
non pregnant n =  12 3680 683
pregnant n = 13 4003 1119
sp aborter n =21 16457 7760
Table 5.5 H-2R Results
Because the data were not normally distributed, a non parametric statistical analysis 
(Mann Whitney) was carried out.
There was no significant difference in the results o f samples from non pregnant 
women compared to those o f normal pregnant women.
Results o f spontaneous aborters were found to be significantly higher than both non 
pregnant and pregnant results (p< 0.0001 in both instances).
The following box and whiskers plot shows minimum, maximum, inter-quartile 
and median values for each group.
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5.5 Discussion
Table 5.6 gives a summary o f significant differences found between the various
groups.
n-i n-2R n-6 n -8
non pregnant v pregnant nsd nsd nsd nsd
non pregnant v spontaneous 
aborters
p = 0.0001
(sp ab i )
p < 0.0001 
(sp ab T)
p = 0.001
(sp ab T)
nsd
non pregnant v recurrent 
aborter
nsd kkkk p = 0.0097 
(rec ab t )
p=0.0071 
(rec ab T)
pregnant v spontaneous 
aborters
p = 0.0001
(sp ab ^
p < 0.0001
(sp ab T)
nsd nsd
spontaneous aborters v 
recurrent aborter
p < 0.0001
(sp ab i )
kkkk nsd nsd
non pregnant v follow up 
pregnant
kkkk •kkkk p=0.016
(fu preg t )
kkkk
non pregnant v termination kkkk kkkk p = 0.003 
(term T)
kkkk
T higher than -I lower than **** not applicable
Table 5.6. Interleukins Summary o f Results
This study found there to be no difference in the pattern o f cytokines measured 
between non pregnant women and healthy pregnant women. Samples from 
pregnant women were taken in the first trimester o f pregnancy. Other studies have 
found that levels of cytokines increased with gestational age. 11-6 and 11-8 were
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found in amniotic fluid in the latter half o f gestation, with 11-8 being detected in 
blood plasma at this time (Ollah 1996). II-1 and 11-6 were found to increase with 
gestational age (Austgulen 1994). I1-2R was found in one study to be raised in 
retroplacental, but not peripheral serum in normal pregnancy (Lien 1996).
Spontaneous aborters were found to have lower II-1 levels and raised I1-2R when 
compared to both non pregnant and healthy pregnant women. Why this should 
occur is unclear, but raised I1-2R is found in cases o f transplant rejection (Colvin
1987) and autoimmunity (Xiu 1994, Kroemer 1989). As discussed in chapter one the 
rejection o f the foetal allograft and autoimmunity are two mechanisms often cited as 
possible causes o f spontaneous abortion. Raised levels o f 11-6 and 11-8 may be 
indicators o f inflammatory response and fever or infection which are also discussed 
in chapter one possible mechanisms o f spontaneous abortion.
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Chapter Six
Thyroid Auto-antibodies
6.1 The Thyroid
T h e thyroid gland is an endocrine gland that sits as tw o lobes, connected by 
an isthm us, on either side o f  the trachea, ju s t below  the larynx (figure 6.1). It weighs 
approxim ately 20 grams and consists o f  cuboidal epithelial cells arranged into sacs 
called follicles (figure 6.2) (M e ougal 1992a). T h e  thyroid secretes the horm ones 
thyroxine (T 4) and tri-iodothyronine (T 3). C alcitonin  (thyrocalcitonin) is p roduced 
by the parafollicular or C-cells o f  the thyroid (Austin 1981). T he  parathyroid glands 
w hich are situated behind the thyroid, produce parathyroid horm one (P T H ). 
T hyroid  horm ones affect the grow th rate and m etabolism  o f  all o f  the body's cells. 
T hey  control reflexes and regulate the rate at w hich the tissues produce energy. 
Thyroxine regulates the rate o f  oxygen consum ption  and the m etabolic rate (the rate 
w hich the body burns up its fuel). C alcitonin and P T H  function to help m aintain 
hom oeostasis o f  blood calcium  (Breslau 1992).
para thy ro ids
thyroid left lobe
thyroid right lobe
Figure 6.1 T he thy ro id
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Figure 6.2 Follicle & follicular cell
T 3 and T4 are composed o f multiple copies o f the amino acid tyrosine, bound to 
either three or four iodine molecules (figures 6.3 & 6.4) (McDougal 1992b). The 
epithelial cells o f the thyroid are arranged in spherical structures called follicles. The 
thyroid hormones are stored in the colloid substance that fills the follicles, bound to 
the protein thyroglobulin (Tg). Thyroid hormones are released from the 
breakdown o f Tg into the extracellular space and plasma, largely bound to the three 
transport proteins thyroxine binding globulin (TBG), thyroxine binding pre 
albumin (TBPA) and albumin. The small amounts o f  T3 (0.3%) and T4 (0.03%) not 
bound to transport proteins are called free hormones. The formation and release o f
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T 3 and T4 are under the control o f thyroid stimulating hormone (TSH), a 
glycoprotein with two peptide chains, which is produced in, and excreted from, 
specific cells in the anterior pituitary.
^N H 2
CH2-CH
\
COOH
Figure 6.3. The structure o f T3
.NH2 
CH2-CH
\
COOH
Figure 6.4. T he structure o f  T4
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6.2 Thyroid Disease
An individual with normal circulating levels o f the thyroid hormones is said 
to be euthyroid.
Levels o f thyroid hormones insufficient to the requirement o f the body gives rise to 
hypothyroidism. Figures given in the literature for the incidence o f this disease vary. 
In the U K  3.3 per 1,000 are affected (Wartofsky 1996) or up to 1% o f the population 
(McDougal 1992b) Hypothyroidism is 5-10 times more commonly found in 
women than in men and increases in frequency with age so prevalence rates will 
vary with the age o f population sampled.
Hypothyroid patients may have a disease o f the thyroid (primary hypothyroidism), 
pituitary (secondary hypothyroidism) or hypothalamus (tertiary hypothyroidism) 
O f these the most common is primary hypothyroidism. In overt primary 
hypothyroidism serum TSH levels are invariably raised, T4 levels are depressed and 
thyroid antibodies are often found, reflecting the underlying autoimmune process 
that is believed to be the usual cause (Tunbridge 1981). Hashimoto’s thyroiditis, 
first described in 1912, is a disease, mostly found in women over forty, in which 
thyroid insufficiency is accompanied by the presence o f gpitre (an enlargement of 
the thyroid).
Excess levels o f thyroid hormones is hyperthyroidism or thyrotoxicosis (McDougal 
1992d). In the U K  figures given in the literature for the prevalence o f thyrotoxicosis 
in women vary from 2.5-3.0 per 1,000 (Wartofsky 1996) to around 2%, a figure 
which is 5-10 fold higher than that for males (Weetman 1994). The commonest 
syndrome to cause hyperthyroidism is diffuse toxic goitre or Graves’ disease, an
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organ specific autoimmune disease where there is production o f anti TSH receptor 
antibodies. Symptoms o f Graves’ disease include tachycardia, nervousness, weight 
loss and palpitations as well as gpitre. Graves’ disease is associated with other 
autoimmune disorders, both organ specific and generalised, more frequently than 
by chance (McDougal 1992c).
Autoimmune thyroid disorders such as Graves’ disease or Hashimoto’s disease are 5 
to 8 times more common in women than in men (Wartofsky 1996).
6.2.1 Thyroid Disease and Pregnancy
In normal pregnancy the thyroid undergoes changes in both structure and 
function. By the end o f the first trimester renal tubular reabsorption o f iodide falls, 
resulting in increased urinary excretion o f iodide and a relative deficiency in plasma 
iodide. To compensate for this the thyroid triples its uptake o f iodide from the 
blood (Rodin 1989). This adaptation is usually sufficient to maintain production o f 
thyroid hormones, but where there is a dietary iodine deficiency, pregnant women 
may develop a goitre.
Because o f oestrogen mediated increase in TBG synthesis the concentration o f 
serum TBG doubles by the twelfth week o f pregnancy. This results in increased 
amounts o f bound T3 and T 4 in the serum and this is reflected in measurements o f 
total T3 and T 4 in the serum.
Thyroid disease is estimated to complicate 0.5% o f all pregnancies (Rodin 1989).
Some thyroid diseases, particularly autoimmune thyroid disease, tend to be less 
severe during pregnancy. During pregnancy levels o f circulating lymphocyte subsets 
such as CD4+ve are reduced and natural killer cell activity is depressed
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(Lazarus 1994). This modification o f the maternal immune response appears to have 
a significant influence on disease activity in autoimmune disorders.
Hyperthyroidism is rare in pregnant women (prevalence 0.05-0.2%). Graves’ disease 
is the commonest form o f hyperthyroidism in pregnancy, though this disease may 
go into remission during pregnancy due to decreased maternal immunologic 
activity. In some patients the hyperthyroidism is so mild it may gp unnoticed, but 
will relapse in the post partum period. This post partum exacerbation o f the disease 
process must be distinguished from the condition known as post partum thyroid 
disease.
Hypothyroid females are relatively infertile and as a result hypothyroidism is rarely 
found in pregnancy. Where it does occur Hashimoto’s thyroiditis is the commonest 
cause.
Post partum thyroid disease is a transient thyroid dysfunction associated with 
painless goitre which occurs after childbirth in 7% o f previously healthy women 
with no personal or family history o f thyroid disease (Barnett 1994). Anti thyroid 
peroxidase (anti-TPO) antibodies are found in the serum and there is a marked 
lymphocytic infiltration o f the thyroid gland. A recent study (Lazarus 1996) found 
that 73 women out o f 152 with anti TPO  antibodies in the serum while pregnant, 
went on to suffer from post partum thyroiditis, compared to a group o f 239 
controls, none o f whom showed symptoms o f the disease.
6.3 Thyroid Auto-antibodies
Thyroid cells have three main antigens against which antibodies are 
produced. These are thyroid stimulating hormone receptor, thyroid microsomes (or
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thyroid peroxidase, TPO) and thyroglobulin (Tg). The antibodies produced to 
these antigens are respectively called thyrotrophin receptor antibody (TRAb), anti- 
TPO  and anti Tg.
Anti Tg and anti TPO  have been implicated as potentially important factors in 
miscarriage (Stagnaro-Green et al 1990). Acceptance o f the foetal allograft is a major 
physiologic response to pregnancy. The immune system is thought to be 
responsible for many miscarriages, with autoimmunity recently implicated as an 
important factor (Scott et al 1987). Stagnaro-Green et al found that the tendency to 
secrete detectable levels o f anti Tg and anti TPO  was significantly correlated with an 
increased rate o f miscarriage. They concluded that anti Tg and anti TPO  were 
independent markers o f “at risk” pregnancy.
6.4 Subject Population
Using ELISA kits, with methods as described in chapter two, anti Tg and 
anti TPO  levels were measured in the following groups o f patients.
Group 1.10 healthy, non pregnant women not on the oral contraceptive pill, with a 
mean menstrual cycle o f 28 plus or minus 3 days duration.
Group 2. 11 healthy women in the first trimester o f an ongoing pregnancy.
Group 3. 11 women admitted with spontaneous abortion. Blood was obtained from 
these women prior to them going to surgery for evacuation o f the retained products 
o f conception.
Group 4. 10 healthy women admitted to hospital for termination o f pregnancy.
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Blood was taken from these women 2-3 hours after termination.
Group5. 11 women with a history o f recurrent miscarriage ie more than three 
miscarriages, no live births. All were pregnant at time o f sampling.
Samples were sent to the haematology laboratories in GRI for estimation o f 
anticardiolipin and antinuclear antibodies as there an association has been reported 
between these antibodies and pregnancy loss (MacLean 1994). All patients were 
negative for these antibodies.
All blood samples were separated and stored as serum in -20°C freezer till the day 
o f  the assay when they were removed and allowed to come to room temperature.
Routine thyroid function tests (T4and TSH) were carried out in the GRI 
biochemistry department on samples from all groups. The normal reference ranges 
for these tests are:
t 4 T SH
non pregnant 55-144 nmol/1 <5 mU/1
pregnant 55-158 nmol/1 <5 mU/1
Table 6.1. Normal reference ranges for T4 and TSH
In accordance with the literature received with the kits anti Tg values greater than 
8U/ml and anti TPO  values greater than lU /m l are taken to be positive.
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6.5 Results
The results are shown in table 6.2 as mean ± standard deviation. Statistical 
significance was tested for using the Mann Whitney U  test. Chi-squared analysis 
was performed on the data from antibody analysis.
Group Gestation n mean t 4 TSH antibody +ve
(weeks) age
(years)
(nmol/1) (U/ml)
Tg TPO
1
non preg
10 28.4 ± 3.2 99 ±29 1.1 ±0.5 0 0
2
pregnant
9.4 ±1.1 11 24.5 ±4.1 143 ±39 1.3 ±0.3 0 0
3
sp. ab.
9.3+2.0 11 25.5 ±3.8 110 ±32 1.0 ±0.5 0 0
4
termin.
6.8 ±2.2 10 25.7 ±6.9 114 ±27 2.0 ±2.2 1 1
5
rec. ab.
7.8 ±1.4 11 30.4 ±4.8 94 ± 9 1.7 ± 0.9 1 3
Table 6.2. Thyroid Test Results
Total T 4 levels were significantly lower in groups 4 and 5 (induced and recurrent 
abortion) when compared to group 2 (healthy pregnant) with P values <  0.001 and 
< 0.03 respectively.
No thyroid antibodies were detected in groups 1, 2 or 3 (healthy, non pregnant, 
healthy pregnant and spontaneous aborters). 2 out o f 10 termination patients and 4 
out o f 11 recurrent aborters had detectable thyroid antibodies. Chi-squared analysis
o f this data showed the prevalence o f thyroid antibodies to be significantly higher 
(p< 0.01) in women with a history o f recurrent abortion.
6.6 Discussion
Recently there have been a number o f studies looking at thyroid antibodies 
in pregnancy. In the study undertaken by Stagnaro-Green et al (1990) 552 first 
trimester women were involved. They found 20% to be thyroid antibody positive. 
O f these 17% miscarried compared with only 8.4% o f the antibody negative women. 
This study did not determine whether the women were first time aborters or 
whether they had a history o f unsuccessful pregnancy. This present study, although 
much smaller than Stagnaro-Green’s has attempted to look at abortion sub groups 
and shows increased incidence o f thyroid antibodies in the group o f recurrent, but 
not spontaneous, aborters.
Although women in the child-bearing age range have a higher incidence o f 
circulating thyroid antibodies than is found in the general population (Vargas et al
1988) no thyroid antibodies were detected in groups 2 and 3, the healthy pregnant 
and spontaneous aborters. A recent study (Pratt et al 1993) found that the incidence 
o f anti-thyroid antibodies in women who have had recurrent abortions was not 
significantly increased compared to a normal random control population. However, 
they found that anti-thyroid antibodies do occur with greater frequency in women 
with a history o f recurrent spontaneous abortion than non-organ-specific- 
autoantibodies.
A role for thyroid hormones in the maintenance o f early pregnancy has been 
implied in a recent study (Maruo et al 1992). This group looked at thyroid function
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results in patients with threatened abortion. They found serum levels o f total T3 
and T 4 and free T 3 and T 4 to be lower in patients who subsequently went on to 
abort than in those who had a successful pregnancy outcome. They found that T 3 
and T4 levels were higher at the onset o f threatened abortion compared to pre 
pregnancy for those women who did not abort, but for those who aborted T3 and T 4 
levels did not rise from the pre pregnancy levels. They concluded from this that 
raised levels o f maternal thyroid hormones may be required to maintain early 
pregnancy. In this present study total T 4 levels were significantly lower in women 
with a history o f miscarriage (p< 0.03) and those undergoing induced abortion (p< 
0.001) when compared to healthy pregnant women. All T4 values were within the 
normal euthyroid range for women in the first trimester o f pregnancy. The reduced 
gestation for these groups compared to the healthy pregnant group may explain in 
part the lower T4 levels.
The findings o f this chapter were published in the European Journal o f 
Endocrinology (Roberts 1996)
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Chapter Seven
Discussion
7.1 Effect of Variation in Menstrual Cycle
The statistical findings with respect to variations in the menstrual cycle are 
summarised in table 7.1.
Immunoglobulins
IgG IgM
nsd nsd
Mitogens
PHA ConA PWM
nsd nsd nsd
Free radical scavengers
PSH LSH Cp. SOD
nsd p =  0 .0 4 6 6
(follicular t  than luteal)
nsd nsd
Table 7.1. Summary o f statistical analyses: variation in menstrual cycle
This study has shown that B cell production o f antibodies or stimulation of 
lymphocytes by mitogens did not significantly differ throughout the menstrual cycle 
in non pregnant women. The time o f sampling within the menstrual cycle would 
thus appear to be an unimportant factor when measuring these parameters. This has 
important implications for other studies.
Free radical scavenger levels were found to remain constant throughout the 
menstrual cycle, with the exception o f lysate thiol levels which were significantly
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higher in the follicular phase than in the luteal phase (p = 0.0467).
7.2 Effect of Normal Pregnancy
The statistical findings with respect the effect o f normal pregnancy are 
summarised in table 7.2.
Immunoglobulins
non-pregnant vs. pregnant
IgG IgM
p = 0.0355 nsd 
(preg 4')
Mitogens
non-pregnant vs. pregnant
PHA ConA PWM
nsd nsd nsd
Free radical scavengers
non-pregnant vs. pregnant
PSH LSH Cp. SOD
nsd nsd p =  0.0001
(preg t)
p =  0.0187 
(Preg *t)
Cytokines
non-pregnant vs. pregnant
IL-1 IL-2R JL-6 IL-8
nsd nsd nsd nsd
Table 7.2. Summary o f statistical analyses: effect o f normal pregnancy.
There were no patients with detectable thyroid antibodies in either group.
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Normal pregnancy is associated with changes in immune function (as can be seen in 
lower IgG levels) and in anti-oxidant levels (as seen in raised caeruloplasmin and 
SOD levels). As discussed in Chapter one, extracellular proteins with a large 
proportion o f disulphide bridges such as IgG or albumin appear to be particularly 
susceptible to hydroxyl and peroxy radical attack. The results in this thesis concur 
with this.
If  the T h2 bias o f pregnancy postulated by Wegmann (1993) and discussed in the 
introduction o f this thesis is correct then B-cells taken from pregnant woman will 
be up-regulated and producing large amounts o f antibody. Stimulation o f these, 
already up regulated cells, might not result in the production o f  large amounts o f 
antibody and the stimulation index would therefore be smaller as was found when 
comparing pregnant with non pregnant women.
These changes were detected in the first trimester o f pregnancy when compared to 
non pregnant women. Whether the immune response causes changes in antioxidant 
levels or vice versa is not clear.
This study has shown changes in anti-oxidant levels in the peripheral circulation of 
healthy pregnant women. Whether these changes are a direct result o f events in the 
uterus is not clear. However, previous workers have shown that free radicals can 
effect certain immune processes. Increased levels o f 11-2 are known to inhibit free 
radical production (Hoffield 1981). Normal pregnancy has been associated with a 
bias towards antibody associated immunity and away from cell mediated immunity 
(the T h2 bias o f pregnancy) (Wegmann 1993). As a result o f this reduced levels o f 
the abortogenic cytokine 11-2 are found. Reduced levels o f 11-2 could explain the 
increased anti-oxidant activity noted in this study. I found lower levels o f anti­
oxidants in spontaneous aborters when compared to normal pregnant women.
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This may be an indication that a failure to mount this T h2 bias o f pregnancy was the 
cause o f miscarriage for some o f these women. These findings suggest that events in 
the uterus influence events in the peripheral circulation.
Cytokine levels were not significantly different in pregnant women when compared 
to non pregnant women. This concurs with findings o f other workers (Austgulen 
1994, Lien 1996) looking at peripheral blood in early pregnancy.
Thyroid antibodies were not detected in the serum o f either non pregnant or 
pregnant women. Other workers, in a larger study, found that 20% o f pregnant 
women had thyroid antibodies (Stagnaro-Green 1990). These women’s past 
pregnancy history was not indicated, while the small group o f pregnant women in 
this present study were primigravidae.
This study looked at peripheral blood. Changes found in peripheral blood may 
reflect what happens in the uterus or indeed may be driven by events in the uterus.
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7.3 Effect of Abortion
The statistical findings with respect the effect o f abortion are summarised 
in table 7.3.
Immunoglobulins
non-pregnant vs. abortion
IgG IgM
nsd nsd
M itogens
non-pregnant vs. abortion
PHA ConA PWM
nsd nsd nsd
Free radical scavengers
non-pregnant vs. abortion
PSH LSH Cp. SOD
nsd nsd p =  0.0048 
(aborters T)
nsd
Cytokines
non-pregnant vs. abortion
IL-1 IL-2R EL-6 IL-8
p = 0.0001 p < 0.0001
(sp ab 4<) (sp ab t )
p=0.001
(sp ab t )
nsd
Table 7.3. Summary o f statistical analyses: effect o f abortion.
There were no thyroid antibodies in the non-pregnant group, 4 out o f 11 recurrent 
aborters were positive for thyroid antibodies.
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Cp levels were higher in women following spontaneous abortion compared to non 
pregnant women. This concurs with another study (Sane 1991) which reported 
evidence o f increased free radical activity in women undergoing abortion (induced 
or spontaneous).
An autoimmune cause for spontaneous abortion is indicated by presence o f thyroid 
antibodies and raised I1-2R. Raised 11-6 may indicate the presence o f an infection 
being the cause o f abortion.
Free radical scavengers
pregnant vs. abortion
PSH LSH Cp SO D
00+ vs. ly  aborters nsd nsd nsd P =  0.0463 
(aborters^)
0+° vs. 1st aborters nsd nsd nsd P =  0.0129 
(aborters^)
0+° vs. all aborters nsd nsd nsd P =  0.0339 
(aborters^)
pregnant vs. ly 
aborters
nsd nsd p=  0.0323 
(aborters -i)
p =  0.0218
(aborters^)
all pregnant vs. all 
aborters
P- 0.0310 
(aborters >1)
nsd nsd P =  0.0023 
(aborters >1)
Cytokines
pregnant vs. abortion
11-1 I1-2R 11-6 11-8
p = 0.0001
(sp ab 4*)
p < 0.0001
(sp ab t )
nsd nsd
Table 7.4. Summary o f statistical analyses: effect o f abortion.
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Spontaneous aborters generally had lower levels o f SOD than pregnant women. 
Although there were limited numbers in this study it appears that these abortions 
were influenced by neither parity nor previous abortions. This information had not 
previously been available.
7.4 Th2 bias of pregnancy
As discussed in the introduction o f this thesis T-helper cells can be sub­
grouped as follows;
T h1 cells produce cytokines detrimental to pregnancy such as 11-2, IFN-y 
and TN F-P and induce N K activity.
T h2 cells produce cytokines beneficial to pregnancy such as 11-3,11-4,11-5 
and 11-10 and induce B-cell production.
The hypothesis that normal pregnancy is allowed to continue because the body 
mounts a response in favour o f humoral (antibody-mediated) and away from 
cellular (T-cell-mediated) immunity is known as the T H2 bias o f pregnancy. Much 
o f the work in this area has been carried out on mice (Chaouat 1995) and in 
ruminants (Martal 1997). Other work on human trophoblast cell lines has been 
reported. In this study peripheral blood has been studied. Although any changes 
found may or may not reflect what is happening in utero, ease o f sampling was the 
main criteria for looking at peripheral blood. Modulations o f cytokine expression in 
the peripheral blood o f third trimester women have been noted recently (Tranchot-
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Diallo 1997).
Some o f the findings discussed in this thesis concur with the T H2 bias o f pregnancy. 
These are:
The lower stimulation index found in IgG production o f pregnant women 
compared to non pregnant women suggests that the B-cells o f pregnant women are 
already in an up regulated state.
Levels o f some anti-oxidants were found to be lower in aborters than levels found in 
blood o f pregnant women. The cytokine 11-2 is known to be raised in cases of 
abortion and it is known that raised 11-2 levels cause a drop in levels o f anti­
oxidants.
I1-2R was raised in samples from aborters when compared to samples from 
pregnant women. I1-2R mediates the action o f 11-2 and is found on the surface o f 
cells stimulated by immune challenge.
It would be of interest for future studies to look at the presence in pregnancy and 
abortion o f other cytokines implicated in the T H2 bias o f pregnancy such as 11-10 
which is said to inhibit T H1 cells. Another interesting area o f research would be to 
look at trophoblast cell lines and the release o f cytokines from these cells on the 
addition o f blood from pregnant or aborting women.
The case for an immune cause o f abortion might be stronger had karyotyping o f all 
abortuses been carried out. Around 50% o f all aborted foetuses are reported to be 
chromosomally abnormal (Simpson, 1980). Karyotyping o f aborted material would 
have enabled me to verify this finding and, importantly, to discount those found to 
be abnormal from the study. Unfortunately, due to the expense o f this technique,
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and because o f current clinical practice, karyotyping was not performed. Had 
samples from women with abnormal foetuses been discarded from the study this 
would possibly have had the effect o f augmenting the prevalence o f abortion caused 
by immunological abnormalities among those women left in the study. Thus, for 
example, anti thyroid antibodies were detected in 2 out o f 10 women who suffered 
spontaneous abortion. If  5 o f these 10 were taken out o f the study because of 
chromosomal abnormality then this leaves 2 out o f the remaining 5 to be antibody 
positive.
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